<?xml version="1.0" encoding="UTF-8"?><html xmlns="http://www.w3.org/1999/xhtml" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:protege="http://protege.stanford.edu/plugins/owl/protege#" xmlns:xsp="http://www.owl-ontologies.com/2005/08/07/xsp.owl#" xmlns:Thesaurus="http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#" xmlns:owl="http://www.w3.org/2002/07/owl#" xmlns:xsd="http://www.w3.org/2001/XMLSchema#" xmlns:rdfs="http://www.w3.org/2000/01/rdf-schema#" xmlns:dublincorens="http://purl.org/dc/elements/1.1/"  version="XHTML+RDFa 1.0" ><body>Int. J. Mol. Sci. 2014, 15, 2431-2453; doi:10.3390/ijms15022431 <br />                                                                                          OPEN ACCESS <br />                                                                              International Journal of <br />                                                                           Molecular Sciences <br />                                                                                      ISSN 1422-0067 <br />                                                                             www.mdpi.com/journal/ijms <br /> Article <br />  <br /> PhosphoTyrosyl Phosphatase Activator of <br /> Plasmodium falciparum: Identification Its <br /> Residues Involved Binding Activation PP2A <br /> Audrey Vandomme 1, Aline Fr&#195;&#169;ville 1, Katia Cailliau 2, Hadidjatou Kalamou 1, <br /> Jean-Fran&#195;&#167;ois Bodart 2, Jamal Khalife 1,* Christine Pierrot 1,* <br /> 1 <br />     Center Infection Immunity Lille, Inserm U1019-CNRS UMR 8204, <br />     University Lille Nord France, Institut Pasteur Lille, 1 Rue du Professeur Calmette, <br />     Lille 59019, Cedex, France; E-Mails: audrey.vandomme@pasteur-lille.fr (A.V.); <br />     alinekatia.freville@gmail.com (A.F.); hkalamou@gmail.com (H.K.) <br /> 2 <br />     EA4479, IFR147, Laboratoire R&#195;&#169;gulation des Signaux Division, SN3, <br />     Universit&#195;&#169; des Sciences et Technologies Lille, Villeneuve d&#226;&#8364;&#8482;Ascq 59655, France; <br />     E-Mails: katia.maggio@univ-lille1.fr (K.C.); Jean-Francois.Bodart@univ-lille1.fr (J.-F.B.) <br />  <br /> * Authors correspondence addressed; E-Mails: jamal.khalife@pasteur-lille.fr (J.K.); <br />   christine.pierrot@pasteur-lille.fr (C.P.); Tel.: +33-3-2087-7968 (J.K. &amp; C.P.); <br />   Fax: +33-3-2087-7888 (J.K. &amp; C.P.). <br />  <br /> Received: 4 December 2013; revised form: 10 January 2014 / Accepted: 22 January 2014 / <br /> Published: 11 February 2014 <br />  <br />  <br />       <span id='am-1' about='protege:abstract' typeof='owl:Thing'>Abstract</span>: In Plasmodium falciparum (Pf), causative agent deadliest form of <br />       malaria, tight regulation phosphatase activity crucial development the <br />       parasite. In study, identified characterized PfPTPA homologous <span id='am-4' about='protege:TO' typeof='owl:Thing'>to</span> <br />       PhosphoTyrosyl Phosphatase Activator, activator protein phosphatase 2A a <br />       major phosphatase involved biological processes eukaryotic cells. The PfPTPA <br />       sequence analysis revealed amino acids involved interaction with <br />       PP2A human conserved P. falciparum. Localization studies showed PfPTPA <br />       PfPP2A present compartment blood stage parasites, suggesting a <br />       possible interaction proteins. In vitro binding functional studies revealed <br />       PfPTPA binds activates PP2A. <span id='am-161' about='Thesaurus:TESSE01' typeof='owl:Thing'><span id='am-162' property="rdfs:label" content="RNA Interference" datatype="rdf:PlainLiteral"></span><span id='am-163' property="rdfs:label" content="Mutation" datatype="rdf:PlainLiteral"></span><span id='am-164' property="rdfs:label" content="Mutation analysis" datatype="rdf:PlainLiteral"></span><span id='am-165' property="rdfs:label" content="Gene mutation" datatype="rdf:PlainLiteral"></span><span id='am-166' property="Thesaurus:Preferred_Name" content="knockout" datatype="rdf:PlainLiteral"></span><span id='am-167' property="rdfs:label" content="Gene knockout" datatype="rdf:PlainLiteral"></span><span id='am-168' property="Thesaurus:Preferred_Name" content="phenotype" datatype="rdf:PlainLiteral"></span><span id='am-169' property="Thesaurus:Preferred_Name" content="Novel mutation" datatype="rdf:PlainLiteral"></span><span id='am-170' property="Thesaurus:code" content="TEESS22" datatype="rdf:PlainLiteral"></span><span id='am-171' property="Thesaurus:Preferred_Name" content="survival" datatype="rdf:PlainLiteral"></span><span id='am-172' property="Thesaurus:code" content="TEESS15" datatype="rdf:PlainLiteral"></span><span id='am-173' property="Thesaurus:Preferred_Name" content="Insertion mutation" datatype="rdf:PlainLiteral"></span><span id='am-174' property="Thesaurus:code" content="TEESS06" datatype="rdf:PlainLiteral"></span><span id='am-175' property="rdfs:label" content="Nonsense mutation" datatype="rdf:PlainLiteral"></span><span id='am-176' property="rdfs:label" content="knockout" datatype="rdf:PlainLiteral"></span><span id='am-177' property="Thesaurus:Preferred_Name" content="Gene knockout" datatype="rdf:PlainLiteral"></span><span id='am-178' property="Thesaurus:code" content="TEESS19" datatype="rdf:PlainLiteral"></span><span id='am-179' property="Thesaurus:Preferred_Name" content="null mutants" datatype="rdf:PlainLiteral"></span><span id='am-180' property="rdfs:label" content="null mutants" datatype="rdf:PlainLiteral"></span><span id='am-181' property="Thesaurus:Preferred_Name" content="Mutation" datatype="rdf:PlainLiteral"></span><span id='am-182' property="rdfs:label" content="Missense mutation" datatype="rdf:PlainLiteral"></span><span id='am-183' property="rdfs:label" content="null allele" datatype="rdf:PlainLiteral"></span><span id='am-184' property="Thesaurus:Preferred_Name" content="cell survival" datatype="rdf:PlainLiteral"></span><span id='am-185' property="rdfs:label" content="cell survival" datatype="rdf:PlainLiteral"></span><span id='am-186' property="rdfs:label" content="Insertion mutation" datatype="rdf:PlainLiteral"></span><span id='am-187' property="Thesaurus:Preferred_Name" content="Gene mutation" datatype="rdf:PlainLiteral"></span><span id='am-188' property="Thesaurus:code" content="TEESS02" datatype="rdf:PlainLiteral"></span><span id='am-189' property="Thesaurus:code" content="TEESS13" datatype="rdf:PlainLiteral"></span><span id='am-190' property="rdfs:label" content="phenotype" datatype="rdf:PlainLiteral"></span><span id='am-191' property="Thesaurus:Preferred_Name" content="RNA Interference" datatype="rdf:PlainLiteral"></span><span id='am-192' property="rdfs:label" content="Induced mutation" datatype="rdf:PlainLiteral"></span><span id='am-193' property="Thesaurus:code" content="TEESS25" datatype="rdf:PlainLiteral"></span><span id='am-194' property="Thesaurus:code" content="TEESS04" datatype="rdf:PlainLiteral"></span><span id='am-195' property="Thesaurus:Preferred_Name" content="RNA interference pathway" datatype="rdf:PlainLiteral"></span><span id='am-196' property="Thesaurus:Preferred_Name" content="Targeted mutation" datatype="rdf:PlainLiteral"></span><span id='am-197' property="rdfs:label" content="survival" datatype="rdf:PlainLiteral"></span><span id='am-198' property="rdfs:label" content="Deleterious mutation" datatype="rdf:PlainLiteral"></span><span id='am-199' property="Thesaurus:Preferred_Name" content="Silent mutation" datatype="rdf:PlainLiteral"></span><span id='am-200' property="Thesaurus:code" content="TEESS17" datatype="rdf:PlainLiteral"></span><span id='am-201' property="Thesaurus:Preferred_Name" content="Deleterious mutation" datatype="rdf:PlainLiteral"></span><span id='am-202' property="Thesaurus:Preferred_Name" content="Knock-out" datatype="rdf:PlainLiteral"></span><span id='am-203' property="Thesaurus:code" content="TEESS01" datatype="rdf:PlainLiteral"></span><span id='am-204' property="Thesaurus:Preferred_Name" content="null allele" datatype="rdf:PlainLiteral"></span><span id='am-205' property="rdfs:label" content="Silent mutation" datatype="rdf:PlainLiteral"></span><span id='am-206' property="Thesaurus:code" content="TEESS10" datatype="rdf:PlainLiteral"></span><span id='am-207' property="Thesaurus:code" content="TEESS24" datatype="rdf:PlainLiteral"></span><span id='am-208' property="Thesaurus:Preferred_Name" content="Point mutation" datatype="rdf:PlainLiteral"></span><span id='am-209' property="Thesaurus:Preferred_Name" content="Mutation analysis" datatype="rdf:PlainLiteral"></span><span id='am-210' property="Thesaurus:Preferred_Name" content="Nonsense mutation" datatype="rdf:PlainLiteral"></span><span id='am-211' property="rdfs:label" content="Frameshift mutation" datatype="rdf:PlainLiteral"></span><span id='am-212' property="Thesaurus:Preferred_Name" content="Germline mutation" datatype="rdf:PlainLiteral"></span><span id='am-213' property="Thesaurus:code" content="TEESS20" datatype="rdf:PlainLiteral"></span><span id='am-214' property="Thesaurus:code" content="TEESS16" datatype="rdf:PlainLiteral"></span><span id='am-215' property="Thesaurus:code" content="TEESS18" datatype="rdf:PlainLiteral"></span><span id='am-216' property="rdfs:label" content="Novel mutation" datatype="rdf:PlainLiteral"></span><span id='am-217' property="rdfs:label" content="Deletion mutation" datatype="rdf:PlainLiteral"></span><span id='am-218' property="rdfs:label" content="RNA interference pathway" datatype="rdf:PlainLiteral"></span><span id='am-219' property="Thesaurus:code" content="TEESS05" datatype="rdf:PlainLiteral"></span><span id='am-220' property="rdfs:label" content="Knock-out" datatype="rdf:PlainLiteral"></span><span id='am-221' property="rdfs:label" content="Germline mutation" datatype="rdf:PlainLiteral"></span><span id='am-222' property="Thesaurus:code" content="TEESS12" datatype="rdf:PlainLiteral"></span><span id='am-223' property="rdfs:label" content="lethal phenotype" datatype="rdf:PlainLiteral"></span><span id='am-224' property="Thesaurus:code" content="TEESS21" datatype="rdf:PlainLiteral"></span><span id='am-225' property="Thesaurus:code" content="TEESS03" datatype="rdf:PlainLiteral"></span><span id='am-226' property="Thesaurus:code" content="TEESS08" datatype="rdf:PlainLiteral"></span><span id='am-227' property="rdfs:label" content="Point mutation" datatype="rdf:PlainLiteral"></span><span id='am-228' property="rdfs:label" content="Targeted mutation" datatype="rdf:PlainLiteral"></span><span id='am-229' property="Thesaurus:Preferred_Name" content="lethal phenotype" datatype="rdf:PlainLiteral"></span><span id='am-230' property="Thesaurus:code" content="TEESS09" datatype="rdf:PlainLiteral"></span><span id='am-231' property="Thesaurus:code" content="TEESS23" datatype="rdf:PlainLiteral"></span><span id='am-232' property="Thesaurus:Preferred_Name" content="Frameshift mutation" datatype="rdf:PlainLiteral"></span><span id='am-233' property="Thesaurus:code" content="TEESS07" datatype="rdf:PlainLiteral"></span><span id='am-234' property="Thesaurus:Preferred_Name" content="Missense mutation" datatype="rdf:PlainLiteral"></span><span id='am-235' property="Thesaurus:code" content="TEESS11" datatype="rdf:PlainLiteral"></span><span id='am-236' property="Thesaurus:Preferred_Name" content="Induced mutation" datatype="rdf:PlainLiteral"></span><span id='am-237' property="Thesaurus:Preferred_Name" content="Deletion mutation" datatype="rdf:PlainLiteral"></span><span id='am-238' property="Thesaurus:code" content="TEESS14" datatype="rdf:PlainLiteral"></span>Mutation</span> studies showed residues <br />       (V283, G292 M296) PfPTPA indispensable interaction G292 <br />       residue essential activity. In P. falciparum, genetic studies suggested the <br />       essentiality PfPTPA completion intraerythrocytic parasite lifecycle. Using <br />       Xenopus oocytes, showed PfPTPA blocked G2/M transition. Taken together, <br />  Int. J. Mol. Sci. 2014, 15                                                                          2432 <br />  <br />       data suggest PfPTPA play role regulation P. falciparum cell <br />       cycle PfPP2A regulatory activity. <br />  <br />       Keywords: Plasmodium; PTPA; PP2A; phosphatase; dephosphorylation <br />  <br />  <br />  <br /> 1. Introduction <br />  <br />     Most processes eukaryotic cells control protein-protein interactions, notably in <br /> the case enzymes regulated post translational modifications by <br /> protein interacting partners direct control activities. Protein phosphatases group of <br /> enzymes counterbalance action kinases modulate proteins functions modifications <br /> of phosphorylation status. Unlike kinases, phosphatases belong distinct protein/gene <br /> families number, putatively experimentally identified different organisms, fewer <br /> than kinases [1,2]. This difference, fact phosphatases dephosphorylate diverse <br /> substrates vitro, raised question specificity phosphatases their <br /> regulation. Based observations accumulated past decade, mainly major <br /> serine/threonine phosphatases PP1 PP2A, clear-cut evidence localization, <br /> substrate specificity magnitude activity accomplished capacity catalytic subunit <br /> to interact diverse regulatory proteins. For PP1, 200 interacting proteins been <br /> identified using variety biochemical, functional genetic approaches 129 proteins <br /> have characterized [3&#226;&#8364;&#8220;5]. In contrast, seven regulators described PP2A [6&#226;&#8364;&#8220;11] <br /> including I2PP2A PhosphoTyrosyl Phosphatase Activator (PTPA) best characterized <br /> regulators. For phosphatases, observed regulators essential the <br /> catalytic subunit itself. In case PP2A, converging studies demonstrated involvement of <br /> PTPA, known PP2A activator protein, activation loop PP2A cell growth and <br /> <span id='am-5' about='Thesaurus:TESSE01' typeof='owl:Thing'><span id='am-6' property="Thesaurus:Preferred_Name" content="Mutation" datatype="rdf:PlainLiteral"></span><span id='am-7' property="Thesaurus:code" content="TEESS04" datatype="rdf:PlainLiteral"></span><span id='am-8' property="Thesaurus:code" content="TEESS03" datatype="rdf:PlainLiteral"></span><span id='am-9' property="rdfs:label" content="Deleterious mutation" datatype="rdf:PlainLiteral"></span><span id='am-10' property="Thesaurus:Preferred_Name" content="null allele" datatype="rdf:PlainLiteral"></span><span id='am-11' property="Thesaurus:Preferred_Name" content="Novel mutation" datatype="rdf:PlainLiteral"></span><span id='am-12' property="Thesaurus:code" content="TEESS06" datatype="rdf:PlainLiteral"></span><span id='am-13' property="rdfs:label" content="Targeted mutation" datatype="rdf:PlainLiteral"></span><span id='am-14' property="Thesaurus:Preferred_Name" content="null mutants" datatype="rdf:PlainLiteral"></span><span id='am-15' property="Thesaurus:code" content="TEESS18" datatype="rdf:PlainLiteral"></span><span id='am-16' property="Thesaurus:Preferred_Name" content="Mutation analysis" datatype="rdf:PlainLiteral"></span><span id='am-17' property="Thesaurus:Preferred_Name" content="lethal phenotype" datatype="rdf:PlainLiteral"></span><span id='am-18' property="Thesaurus:code" content="TEESS12" datatype="rdf:PlainLiteral"></span><span id='am-19' property="Thesaurus:code" content="TEESS25" datatype="rdf:PlainLiteral"></span><span id='am-20' property="rdfs:label" content="Deletion mutation" datatype="rdf:PlainLiteral"></span><span id='am-21' property="Thesaurus:Preferred_Name" content="phenotype" datatype="rdf:PlainLiteral"></span><span id='am-22' property="Thesaurus:code" content="TEESS07" datatype="rdf:PlainLiteral"></span><span id='am-23' property="Thesaurus:code" content="TEESS17" datatype="rdf:PlainLiteral"></span><span id='am-24' property="Thesaurus:code" content="TEESS02" datatype="rdf:PlainLiteral"></span><span id='am-25' property="rdfs:label" content="Gene knockout" datatype="rdf:PlainLiteral"></span><span id='am-26' property="rdfs:label" content="lethal phenotype" datatype="rdf:PlainLiteral"></span><span id='am-27' property="Thesaurus:Preferred_Name" content="RNA Interference" datatype="rdf:PlainLiteral"></span><span id='am-28' property="rdfs:label" content="Germline mutation" datatype="rdf:PlainLiteral"></span><span id='am-29' property="rdfs:label" content="Silent mutation" datatype="rdf:PlainLiteral"></span><span id='am-30' property="Thesaurus:Preferred_Name" content="Frameshift mutation" datatype="rdf:PlainLiteral"></span><span id='am-31' property="rdfs:label" content="Missense mutation" datatype="rdf:PlainLiteral"></span><span id='am-32' property="Thesaurus:code" content="TEESS10" datatype="rdf:PlainLiteral"></span><span id='am-33' property="Thesaurus:Preferred_Name" content="Deleterious mutation" datatype="rdf:PlainLiteral"></span><span id='am-34' property="rdfs:label" content="Nonsense mutation" datatype="rdf:PlainLiteral"></span><span id='am-35' property="rdfs:label" content="survival" datatype="rdf:PlainLiteral"></span><span id='am-36' property="Thesaurus:Preferred_Name" content="Induced mutation" datatype="rdf:PlainLiteral"></span><span id='am-37' property="rdfs:label" content="Frameshift mutation" datatype="rdf:PlainLiteral"></span><span id='am-38' property="rdfs:label" content="Knock-out" datatype="rdf:PlainLiteral"></span><span id='am-39' property="rdfs:label" content="phenotype" datatype="rdf:PlainLiteral"></span><span id='am-40' property="rdfs:label" content="Gene mutation" datatype="rdf:PlainLiteral"></span><span id='am-41' property="Thesaurus:code" content="TEESS19" datatype="rdf:PlainLiteral"></span><span id='am-42' property="Thesaurus:Preferred_Name" content="knockout" datatype="rdf:PlainLiteral"></span><span id='am-43' property="Thesaurus:Preferred_Name" content="Gene knockout" datatype="rdf:PlainLiteral"></span><span id='am-44' property="Thesaurus:Preferred_Name" content="survival" datatype="rdf:PlainLiteral"></span><span id='am-45' property="Thesaurus:code" content="TEESS05" datatype="rdf:PlainLiteral"></span><span id='am-46' property="Thesaurus:Preferred_Name" content="Nonsense mutation" datatype="rdf:PlainLiteral"></span><span id='am-47' property="Thesaurus:Preferred_Name" content="Knock-out" datatype="rdf:PlainLiteral"></span><span id='am-48' property="rdfs:label" content="cell survival" datatype="rdf:PlainLiteral"></span><span id='am-49' property="Thesaurus:code" content="TEESS14" datatype="rdf:PlainLiteral"></span><span id='am-50' property="Thesaurus:Preferred_Name" content="Missense mutation" datatype="rdf:PlainLiteral"></span><span id='am-51' property="Thesaurus:code" content="TEESS01" datatype="rdf:PlainLiteral"></span><span id='am-52' property="Thesaurus:Preferred_Name" content="Insertion mutation" datatype="rdf:PlainLiteral"></span><span id='am-53' property="Thesaurus:Preferred_Name" content="cell survival" datatype="rdf:PlainLiteral"></span><span id='am-54' property="Thesaurus:code" content="TEESS20" datatype="rdf:PlainLiteral"></span><span id='am-55' property="Thesaurus:Preferred_Name" content="Targeted mutation" datatype="rdf:PlainLiteral"></span><span id='am-56' property="Thesaurus:code" content="TEESS15" datatype="rdf:PlainLiteral"></span><span id='am-57' property="Thesaurus:code" content="TEESS08" datatype="rdf:PlainLiteral"></span><span id='am-58' property="Thesaurus:code" content="TEESS24" datatype="rdf:PlainLiteral"></span><span id='am-59' property="Thesaurus:code" content="TEESS16" datatype="rdf:PlainLiteral"></span><span id='am-60' property="Thesaurus:Preferred_Name" content="Gene mutation" datatype="rdf:PlainLiteral"></span><span id='am-61' property="Thesaurus:Preferred_Name" content="Germline mutation" datatype="rdf:PlainLiteral"></span><span id='am-62' property="Thesaurus:code" content="TEESS21" datatype="rdf:PlainLiteral"></span><span id='am-63' property="Thesaurus:Preferred_Name" content="Point mutation" datatype="rdf:PlainLiteral"></span><span id='am-64' property="rdfs:label" content="Mutation analysis" datatype="rdf:PlainLiteral"></span><span id='am-65' property="rdfs:label" content="RNA interference pathway" datatype="rdf:PlainLiteral"></span><span id='am-66' property="Thesaurus:code" content="TEESS23" datatype="rdf:PlainLiteral"></span><span id='am-67' property="Thesaurus:Preferred_Name" content="RNA interference pathway" datatype="rdf:PlainLiteral"></span><span id='am-68' property="rdfs:label" content="Mutation" datatype="rdf:PlainLiteral"></span><span id='am-69' property="rdfs:label" content="null allele" datatype="rdf:PlainLiteral"></span><span id='am-70' property="rdfs:label" content="RNA Interference" datatype="rdf:PlainLiteral"></span><span id='am-71' property="rdfs:label" content="Induced mutation" datatype="rdf:PlainLiteral"></span><span id='am-72' property="rdfs:label" content="Point mutation" datatype="rdf:PlainLiteral"></span><span id='am-73' property="Thesaurus:Preferred_Name" content="Deletion mutation" datatype="rdf:PlainLiteral"></span><span id='am-74' property="Thesaurus:code" content="TEESS22" datatype="rdf:PlainLiteral"></span><span id='am-75' property="rdfs:label" content="Novel mutation" datatype="rdf:PlainLiteral"></span><span id='am-76' property="rdfs:label" content="Insertion mutation" datatype="rdf:PlainLiteral"></span><span id='am-77' property="Thesaurus:code" content="TEESS09" datatype="rdf:PlainLiteral"></span><span id='am-78' property="rdfs:label" content="null mutants" datatype="rdf:PlainLiteral"></span><span id='am-79' property="Thesaurus:code" content="TEESS13" datatype="rdf:PlainLiteral"></span><span id='am-80' property="rdfs:label" content="knockout" datatype="rdf:PlainLiteral"></span><span id='am-81' property="Thesaurus:Preferred_Name" content="Silent mutation" datatype="rdf:PlainLiteral"></span><span id='am-82' property="Thesaurus:code" content="TEESS11" datatype="rdf:PlainLiteral"></span>survival</span> [12&#226;&#8364;&#8220;16]. PTPA purified rabbit skeletal muscle Xenopus laevis oocytes, for <br /> its specific capacity activate PP2A vitro [6]. This activation shown ATP- and <br /> Mg2+-dependent [6]. Subsequently PTPA cloned species sequence alignment <br /> revealed high degree identity (&gt;85%) [17,18]. More recently, PTPA described exhibit a <br /> peptidyl prolyl isomerase activity (PPIase) [19] target proline 190 (P190) of <br /> PP2A conserved PP2A. This novel activity associated ability of <br /> PTPA activate PP2A requires presence ATP-Mg2+ mutant PTPA abolished <br /> PP2A activating function did PPIase activity. In addition, mutated version PP2A <br /> (P190A) shown partially active insensitive activation PTPA [19], <br /> indicating proline essential activation process place. <br />     The crystal structures human PTPA (HuPTPA) yeast orthologs determined [20&#226;&#8364;&#8220;22]. <br /> These structures showed PTPA overall &#206;&#177;-helical structure identified highly conserved <br /> cleft potential region interaction. On basis HuPTPA structure, interaction between <br /> PP2A different PTPA mutants investigated GST-pull revealed residues 18 <br /> (V209, E270, V281, G290, M294 K302) strongly contributed binding PP2A [20]. Although the <br /> diverse biochemical functions PTPA PP2A detected vitro remain better defined under <br />  Int. J. Mol. Sci. 2014, 15                                                                          2433 <br />  <br /> the global cellular spatiotemporal constraints, vivo studies revealed disruption lethal in <br /> yeast controlling progression G1 phase cell cycle [15] G2/M transition [13]. <br />    In Plasmodium falciparum, virulent deadly parasite humans, number of <br /> phosphatases characterized, including PP1 PP2A [23&#226;&#8364;&#8220;39]. Despite importance of <br /> these enzymes direct implication cell cycle shown eukaryotic cells than <br /> Plasmodium, experimental approaches carried identify regulators. <br /> Recently, characterized regulators PfPP1, named PfLRR1 [40], Inhibitor 2 (PfI2) [41] <br /> and Inhibitor 3 (PfI3) [42]. PfLRR1 PfI2, expected, showed strong capacity inhibit the <br /> PfPP1 activity exhibit substantial differences binding motifs PP1. <br /> Unexpectedly, PfI3, unlike human counterpart clearly revealed activation PP1 lack to <br /> complement Inhibitor 3 deficient yeast [42]. Additionally, reverse genetic studies suggested the <br /> above regulators essential blood parasite growth. Finally, peptides derived <span id='am-2' about='protege:FROM' typeof='owl:Thing'>from</span> <br /> PfI2 PfI3 competing main binding site PP1 exhibited anti-plasmodial activity <br /> against blood stage parasites vitro [41,42]. <br />    With respect PP2A, biochemical chromatography approaches combined a <br /> micro-sequencing procedure suggested presence PP2A-like catalytic subunit this <br /> parasite [26]. Subsequently, availability P. falciparum genome, transcriptomic <br /> and proteomic studies confirmed expression different parasite stages. The regulator of <br /> PfPP2A characterized Dobson et al. [43]. These authors reported expression by <br /> P. falciparum homolog Inhibitor 2 PP2A (PfI2PP2A), based fact primary <br /> structure PfI2PP2A exhibited overall identity 28% 55% similarity human <br /> counterpart, PfI2PP2A specifically inhibited PP2A overexpression HeLa cells led <br /> to increase phosphorylation transcription factors. This protein essential asexual <br /> erythrocytic cycle Plasmodium berghei (rodent Plasmodium specie). Indeed, Leiden Malaria <br /> Research Group Istituto Superiore di Sanita failed disrupt PbI2PP2A gene double <br /> crossing (http://www.pberghei.eu/index.php?rmgm=246) despite accessibility locus by <br /> PbI2PP2A-GFP tagging integration (http://www.pberghei.eu/index.php?rmgm=218). Although exact <br /> physiological function PfI2PP2A examined, location cytoplasm P. falciparum <br /> strongly suggests regulatory function place compartment. No regulators <br /> of PfPP2A characterized far. <br />    In present study, report characterization PfPTPA, P. falciparum homolog the <br /> human PhosphoTyrosyl Phosphatase Activator protein able directly bind <br /> to PP2A. In vitro binding studies recombinant wild type mutated proteins showed that <br /> three residues (V283, G292 M296) PfPTPA important interaction. Functional studies <br /> revealed PfPTPA activates PP2A vitro residues (E272, V283, G292, M296 K304) <br /> are involved dramatic loss function mutated PfPTPA G292A protein. In P. falciparum, <br /> genetic studies suggested essentiality PfPTPA completion intraerythrocytic <br /> parasite life cycle. Further studies, using heterologous model, showed PfPTPA interacted with <br /> endogenous PP2A microinjection PfPTPA Xenopus oocytes blocked the <br /> G2/M transition. <br />  Int. J. Mol. Sci. 2014, 15                                                                        2434 <br />  <br /> 2. Results Discussion <br />  <br /> 2.1. Molecular Cloning Sequence Analysis PfPTPA <br />  <br />    The P. falciparum genome encodes single putative PTPA (PF3D7_1430100, 319 amino acids, <br /> 37.4 kDa). The predicted gene contained 5 exons cloned identified <br /> experimentally. We isolated RT-PCR product P. falciparum blood stage total RNA using <br /> primers spanning <span id='am-3' about='xsp:length' typeof='owl:Thing'>length</span> sequence. The complete sequencing independent clones <br /> showed open reading frame 960 bp (Supplementary Figure S1), confirming ORF annotated in <br /> PlasmoDB [44] (www.plasmodb.org). Reciprocal BLASTP analysis using deduced amino acid <br /> sequence query confirmed homology gene product known PTPA. The <br /> comparison human counterpart revealed overall identity 32% (54% homology), reaching <br /> a maximum 40% C-terminal region sequence (Figure 1a). PfPTPA orthologs also <br /> present sequenced rodent human Plasmodium species. The ClustalW program used <br /> to generate alignment Plasmodium PTPA sequences species including <br /> human Toxoplasma gondii sequences. As outgroups, inhibitors PP1 PP2A included. <br /> The resulting alignment used generate maximum likelihood phylogenetic tree. The data <br /> presented Figure 1b clearly shows Plasmodium PTPAs form divergent subgroup with <br /> T. gondii cluster group known PTPAs, confirming relatedness PfPTPA to <br /> PhosphoTyrosyl Phosphatase Activator family (Figure 1b). <br />    For human PTPA, noted analysis crystal structure combined with <br /> amino acid mutation studies revealed amino acids present C-terminal region the <br /> protein (V209, E270, V281, G290, M294 K302) critical function PP2A [20]. In <br /> P. falciparum amino acids conserved PfPTPA correspond to <br /> E272, V283, G292, M296 K304 positions (Figure 1a). To shed light position these <br /> conserved residues global structure PfPTPA, 3D model built using human PTPA <br /> (PDB: 2IXM) template (https://modbase.compbio.ucsf.edu/scgi/modweb.cgi) (Figure 1c,d). <br />    The overall structure showed differences human P. falciparum homologs. <br /> Indeed, human PTPA composed thirteen &#206;&#177; helices &#206;&#178; sheets PfPTPA composed <br /> of sixteen &#206;&#177; helices &#206;&#178; sheet. The &#206;&#177; helices localized identically both <br /> proteins helices HuPTPA subdivided shorter helices PfPTPA <br /> (Supplemental Figure S2). This model shows residues involved PP2A interaction human are <br /> on identical structures residues G292 K304 &#206;&#177; helix structure human not <br /> in P. falciparum. Despite differences, crystal human PTPA PfPTPA model <br /> showed residues periphery shown Figure 1c,d. This similarity suggests <br /> that residues involved binding domain PP2A conserved human and <br /> P. falciparum PTPA. <br />  Int. J. Mol. Sci. 2014, 15                                                                          2435 <br />  <br />       Figure 1. Molecular cloning sequence analysis PfPTPA. (a) Analysis PfPTPA <br />       (PF3D7_1430100) amino acid sequence. PfPTPA aligned human PTPA <br />       (CAA60163.1) using ClustalW Multiple Alignment (BioEdit). The identical residues are <br />       highlighted black similar residues grey. Stars symbolized amino acids involved in <br />       PTPA/PP2A interaction human; (b) Phylogenic tree PTPA family. A maximum <br />       likelihood tree generated 21 PTPA sequences using MEGA5 [45] the <br />       JTT + G + I model 100 bootstrap repetitions. Outgroups formed PP2A inhibitor <br />       2 orthologs (I2PP2A, outgroup 1) PP1 inhibitor 2 orthologs (I2PP1, outgroup 2) PP1 <br />       inhibitor 3 orthologs (I3PP1, outgroup 3); (c) Crystal structure HuPTPA (PDB: 2IXM). <br />       Amino acid residues involved PTPA/PP2A interaction shown red; (d) Structural <br />       model PfPTPA based crystal structure HuPTPA (PDB: 2IXM) using the <br />       ModBase server [46]. Amino acid residues studied work PTPA/PP2A <br />       interaction shown red. <br />  Int. J. Mol. Sci. 2014, 15                                                                         2436 <br />  <br />                                             Figure 1. Cont. <br />  <br />  <br />  <br />  <br /> 2.2. Expression PfPTPA PfPP2A Plasmodium falciparum Localization <br />  <br />    RNA-Seq data available PlasmoDB [44] showed gene transcribed blood <br /> stage parasites, peak late trophozoites (32 h). PfPTPA transcripts identified in <br /> gametocytes protein detected proteomics asexual sexual parasites <br /> examined [47&#226;&#8364;&#8220;49]. Because PTPA activator PP2A [6,20,50], plotted RNA-Seq data of <br /> the obtained PfPTPA. Results depicted Figure 2a showed both <br /> transcripts detectable early stage trophozoites higher level PP2A transcripts <br /> (24 h post infection). In late trophozoites/schizonts (32&#226;&#8364;&#8220;40 h post infection), relative abundance of <br /> both transcripts similar, suggesting PfPP2A activated PfPTPA the <br /> late developmental stages intraerythrocytic lifecycle. <br />    Based observations, sought follow distribution PfPTPA PfPP2A <br /> during intraerythrocytic development cycle. To end, P. falciparum 3D7 strain was <br /> transfected pARL2 constructs mediating episomal expression pfptpa pfpp2a-gfp <br /> full-length sequences (Figure 2b). The use vector Kuhn et al. showed trafficking was <br /> dependent fused protein pfcrt promoter used [51]. Using monoclonal <br /> anti-GFP antibody, immunoblot analysis total extract blood stage parasites expressing <br /> either PfPTPA-GFP PP2A-GFP revealed presence specific bands expected size of <br /> each fused protein (Figure 2c, lanes 2 3), demonstrating integrity fused protein in <br /> transfected parasites. <br />    Examination live parasites transfected pfptpa-gfp showed signal confined <br /> within parasite distribution nucleo-cytoplasmic rings, trophozoites schizonts <br /> (Figure 2d), fluorescence partially overlapped DNA staining. Parasites transfected the <br /> construct containing pfpp2a-gfp showed nucleo-cytoplasmic distribution rings schizonts with <br /> an intense accumulation nucleus late trophozoites (Figure 2e). These results accordance <br /> with previous localization studies mammalian cells showing PTPA PP2A a <br />  Int. J. Mol. Sci. 2014, 15                                                                         2437 <br />  <br /> nucleo-cytoplasmic localization accumulation nucleus human cells progressed into <br /> S phase [52], Fission Yeast [12] respectively. The PfPTPA-GFP PfPP2A-GFP signal was <br /> completely absent digestive food vacuole cytoplasm red blood cells (Figure 2d,e). <br /> The presence PfPP2A PfPTPA cytoplasm nuclear compartments parasite <br /> suggests potential interaction proteins raises question potential regulatory <br /> effect PP2A activity. <br />  <br />       Figure 2. Expression pfptpa pfpp2a gene Plasmodium falciparum and <br />       localization (a) Representation pfptpa (black bars) pfpp2a (grey bars) RNA <br />       expression erythrocytic life cycle P. falciparum. Data plotted from <br />       PlasmoDB [44]; (b) Schematic representation pARL2-pfptpa-gfp and <br />       pARL2-pfpp2a-gfp vectors used episomal expression PfPTPA PfPP2A; <br />       (c) The expression proteins checked western blotting anti-GFP <br />       antibodies separation 15% SDS-PAGE. Lane 1 represents extract wild type <br />       parasites. Lane 2 3 represent extracts PfPTPA PfPP2A transfected parasites <br />       respectively. Expression localization PfPTPA-GFP (d) PfPP2A-GFP (e) <br />       erythrocytic cell cycle P. falciparum analyzed fluorescence <br />       microscopy transfection described experimental section. <br />  Int. J. Mol. Sci. 2014, 15                                                                         2438 <br />  <br /> 2.3. Binding PfPTPA PP2A <br />  <br />    Next, interaction PfPTPA PfPP2A investigated. The production proteins <br /> in E. coli revealed PfPTPA produced soluble non-denaturing conditions, while <br /> PfPP2A obtained active form did activity pNPP, a <br /> canonical substrate phosphatases. In order overcome point, used Xenopus oocytes which <br /> we previously reported able produce Plasmodium proteins [40]. Hence, injected oocytes <br /> with recombinant His tagged-PfPTPA protein cRNA corresponding Myc tagged-PfPP2A <br /> protein. Oocyte lysates prepared mentioned Experimental section used for <br /> co-immunoprecipitation/western blot experiments. As shown Figure 3a, immunoblot analysis of <br /> PfPTPA immunoprecipitates using anti-tag antibodies showed PfPP2A been <br /> co-immunoprecipitated PfPTPA. To ascertain direct interaction PfPTPA PP2A, <br /> together fact PP2A highly conserved different species, human PP2A <br /> commercially available used binding ELISA based assay. Results presented Figure 3b <br /> evidenced capacity PfPTPA bind coated HuPP2A intensity signal was <br /> dependent PfPP2A added. Taken together, data demonstrate PfPTPA <br /> physically interacts PfPP2A support previous results showing direct interaction between <br /> PTPA PP2A [53]. <br />    The fact PTPA conserved species suggests use conserved set of <br /> amino acids interact PP2A. Based sequence comparison depicted Figure 1a, out <br /> of residues involved human PTPA/PP2A interaction conserved Plasmodium. To further <br /> explore role conserved residues PfPTPA binding PfPP2A, PfPTPA versions <br /> containing single mutation critical amino acid residue produced recombinant proteins <br /> and used co-immunoprecipitation assays. As control, PfPTPA protein containing five <br /> mutations (PfPTPA 5mut) produced tested conditions. <br /> Co-immunoprecipitation assays performed lysates oocytes injected wild mutant <br /> His tagged-PfPTPA proteins (PfPTPA E272A, PfPTPA V283A, PfPTPA G292A, PfPTPA M296A and <br /> PfPTPA K304A) cRNA translating Myc tagged-PfPP2A. Results showed the <br /> binding mutants E272A K304A impaired binding mutants V283A, G292A and <br /> M296 abolished (Figure 3c). These results suggest differential binding domain human and <br /> Plasmodium. Indeed, HuPTPA E270 residue essential interaction residues <br /> G290 M294 residues V281 K302 important. Finally, major difference <br /> between human Plasmodium binding PTPA PP2A concerns E270 residue (corresponding <br /> to E272 P. falciparum) critical human Plasmodium. This difference suggests a <br /> differential binding domain related difference tertiary structure PTPA both <br /> organisms. It notable version PfPTPA protein containing mutations did not <br /> interact PfPP2A. Taken together, data confirm V283, G292 M296 residues PfPTPA <br /> are involved interaction PfPP2A. <br />  Int. J. Mol. Sci. 2014, 15                                                                      2439 <br />  <br />       Figure 3. Interaction studies PfPTPA PP2A. (a) Binding PfPTPA PfPP2A in <br />       Xenopus oocyte. Co-immunoprecipitation PfPTPA-PfPP2A complex anti-His <br />       antibodies (recognizing recombinant PfPTPA tagged 6-His) (lanes 2 3) from <br />       microinjected Xenopus extracts. The anti-mouse IgG antibody (lane 1) used a <br />       control. Immunoprecipitates Xenopus oocytes microinjected water (&#226;&#710;&#8217;) or <br />       PfPTPA (+) eluted separated SDS-PAGE transferred nitrocellulose <br />       membrane. Immunoblot analysis performed anti-His antibodies (recognizing <br />       PfPTPA) (upper panel) anti-Myc antibodies (recognizing PfPP2A) (lower panel); <br />       (b) Interaction PfPTPA HuPP2A vitro assessed ELISA based assay. <br />       Increasing quantities biotinylated recombinant PfPTPA added wells coated <br />       human PP2A (100 ng/well) BSA (100 ng/well) negative control. Results are <br />       means &#194;&#177; SEM independent experiments performed duplicate (stars (*) represent <br />       significant differences p = 0.01); (c) Binding mutated PfPTPA PfPP2A in <br />       Xenopus oocytes. Co-immunoprecipitation experiment PfPTPA-PfPP2A complexes <br />       anti-His antibodies (recognizing recombinant wild type mutated PfPTPA) <br />       (upper panel) anti-Myc antibodies (recognizing PfPP2A) (lower panel) from <br />       microinjected Xenopus oocytes. Immunoprecipitates Xenopus oocytes microinjected <br />       water, WT mutated PfPTPA eluted separated SDS-PAGE and <br />       transferred nitrocellulose membrane. Immunoblot analysis performed anti-His <br />       anti-Myc antibodies. <br />  <br />  <br />  <br />  <br /> 2.4. Effect PfPTPA Activity PP2A <br />  <br />    It previously reported PTPA proteins able regulate PP2A increasing its <br /> activity different substrates including, limited to, pNPP substrate [6]. Because all <br /> assays produce recombinant active PfPP2A unsuccessful, PfPTPA able bind <br /> HuPP2A (Figure 3b), function PfPTPA activity HuPP2A assessed. Using a <br />  Int. J. Mol. Sci. 2014, 15                                                                         2440 <br />  <br /> concentration human PP2A range producing linear release phosphate, effect of <br /> wild-type mutated recombinant PfPTPA proteins evaluated described Experimental <br /> section. Results showed significant increase phosphatase activity (up 200%) PP2A <br /> was preincubated PfPTPA wild type (Figure 4). When PfPTPA mutated proteins tested at <br /> 10 nM, observed mutations led complete loss function PfPTPA <br /> (Figure 4). At higher contentration (100 nM), PfPTPA G292A protein unable to <br /> activate PP2A, mutated proteins showed slight increase PP2A activity. The <br /> PfPTPA protein containing mutations inactive concentration used. These data, <br /> together co-immunoprecipitation experiments suggest G292 vital primary <br /> residue activity PfPTPA. It important remember human PTPA residues except <br /> K302 equally essential activity [20]. The fact PfPTPA exhibits residues of <br /> six, key role G292, suggest particular interaction PfPTPA PfPP2A to <br /> adequately adapt activation enzyme specific substrate Plasmodium. <br />  <br />       Figure 4. Effect wild type mutated PfPTPA proteins PP2A activity. The capacity <br />       PfPTPA (WT mutated) regulate HuPP2A assessed using pNPP activity tests. <br />       The human PP2A activity measured 405 nm release p-nitrophenol after <br />       incubation different concentration recombinant WT mutated PfPTPA proteins. <br />       Results presented fold change human PP2A activity means &#194;&#177; SEM of <br />       independent experiments (stars (*) represent significativity p = 0.01). <br />  <br />  <br />  <br />  <br /> 2.5. Genetic Manipulations pfptpa pfpp2a Plasmodium falciparum <br />  <br />    It previously shown disruption pp2a ptpa ortholog genes yeast results in <br /> lethality [14,54]. In mice, reported homozygous null PP2A detected the <br /> embryonic stage viable [55]. To study lack PfPTPA PfPP2A expression <br /> could affect Plasmodium blood stage life cycle, attempted disrupt genes single <br /> crossing-over homologous recombination using pCAM vector (Figure 5a,b). We transfected <br /> blood ring stage parasites 3D7 strain pCAM-BSD-pfptpa pCAM-BSD-pfpp2a <br /> constructs containing 5&apos; fragments derived respective genomic sequences bsd gene <br /> conferring resistance blasticidin (Figure 5a,b). After transfections drug treatments, presence <br /> of construct checked plasmid rescue approach previously described (data shown). <br /> The integration viable parasites analyzed PCR genomic DNA, using <br /> oligonucleotides presented Supplemental Table S1. Template DNA wild parasites used as <br />  Int. J. Mol. Sci. 2014, 15                                                                          2441 <br />  <br /> control. The amplicons corresponding wild locus amplicons diagnostic for <br /> PfPTPA PfPP2A detectable transfected parasites (Figure 5c lanes 1 3, Figure 5d <br /> lanes 1 3). The generation mutant parasites demonstrates accessibility locus. In order <br /> to examine <span id='am-83' about='Thesaurus:TESSE01' typeof='owl:Thing'><span id='am-84' property="Thesaurus:Preferred_Name" content="RNA interference pathway" datatype="rdf:PlainLiteral"></span><span id='am-85' property="rdfs:label" content="Silent mutation" datatype="rdf:PlainLiteral"></span><span id='am-86' property="rdfs:label" content="Knock-out" datatype="rdf:PlainLiteral"></span><span id='am-87' property="rdfs:label" content="Mutation analysis" datatype="rdf:PlainLiteral"></span><span id='am-88' property="Thesaurus:code" content="TEESS02" datatype="rdf:PlainLiteral"></span><span id='am-89' property="rdfs:label" content="survival" datatype="rdf:PlainLiteral"></span><span id='am-90' property="Thesaurus:Preferred_Name" content="Point mutation" datatype="rdf:PlainLiteral"></span><span id='am-91' property="Thesaurus:Preferred_Name" content="cell survival" datatype="rdf:PlainLiteral"></span><span id='am-92' property="Thesaurus:code" content="TEESS10" datatype="rdf:PlainLiteral"></span><span id='am-93' property="Thesaurus:Preferred_Name" content="null mutants" datatype="rdf:PlainLiteral"></span><span id='am-94' property="Thesaurus:Preferred_Name" content="Silent mutation" datatype="rdf:PlainLiteral"></span><span id='am-95' property="Thesaurus:Preferred_Name" content="Targeted mutation" datatype="rdf:PlainLiteral"></span><span id='am-96' property="rdfs:label" content="Point mutation" datatype="rdf:PlainLiteral"></span><span id='am-97' property="Thesaurus:code" content="TEESS19" datatype="rdf:PlainLiteral"></span><span id='am-98' property="rdfs:label" content="Germline mutation" datatype="rdf:PlainLiteral"></span><span id='am-99' property="rdfs:label" content="Nonsense mutation" datatype="rdf:PlainLiteral"></span><span id='am-100' property="Thesaurus:Preferred_Name" content="knockout" datatype="rdf:PlainLiteral"></span><span id='am-101' property="Thesaurus:code" content="TEESS03" datatype="rdf:PlainLiteral"></span><span id='am-102' property="Thesaurus:code" content="TEESS23" datatype="rdf:PlainLiteral"></span><span id='am-103' property="Thesaurus:Preferred_Name" content="Missense mutation" datatype="rdf:PlainLiteral"></span><span id='am-104' property="Thesaurus:code" content="TEESS16" datatype="rdf:PlainLiteral"></span><span id='am-105' property="Thesaurus:Preferred_Name" content="Nonsense mutation" datatype="rdf:PlainLiteral"></span><span id='am-106' property="rdfs:label" content="Deletion mutation" datatype="rdf:PlainLiteral"></span><span id='am-107' property="Thesaurus:Preferred_Name" content="Mutation analysis" datatype="rdf:PlainLiteral"></span><span id='am-108' property="Thesaurus:Preferred_Name" content="Gene mutation" datatype="rdf:PlainLiteral"></span><span id='am-109' property="rdfs:label" content="cell survival" datatype="rdf:PlainLiteral"></span><span id='am-110' property="Thesaurus:Preferred_Name" content="Frameshift mutation" datatype="rdf:PlainLiteral"></span><span id='am-111' property="Thesaurus:code" content="TEESS01" datatype="rdf:PlainLiteral"></span><span id='am-112' property="Thesaurus:Preferred_Name" content="Insertion mutation" datatype="rdf:PlainLiteral"></span><span id='am-113' property="Thesaurus:Preferred_Name" content="Mutation" datatype="rdf:PlainLiteral"></span><span id='am-114' property="rdfs:label" content="null mutants" datatype="rdf:PlainLiteral"></span><span id='am-115' property="rdfs:label" content="Deleterious mutation" datatype="rdf:PlainLiteral"></span><span id='am-116' property="Thesaurus:Preferred_Name" content="Knock-out" datatype="rdf:PlainLiteral"></span><span id='am-117' property="rdfs:label" content="Gene mutation" datatype="rdf:PlainLiteral"></span><span id='am-118' property="rdfs:label" content="Insertion mutation" datatype="rdf:PlainLiteral"></span><span id='am-119' property="Thesaurus:code" content="TEESS12" datatype="rdf:PlainLiteral"></span><span id='am-120' property="Thesaurus:code" content="TEESS18" datatype="rdf:PlainLiteral"></span><span id='am-121' property="Thesaurus:code" content="TEESS24" datatype="rdf:PlainLiteral"></span><span id='am-122' property="Thesaurus:Preferred_Name" content="phenotype" datatype="rdf:PlainLiteral"></span><span id='am-123' property="Thesaurus:Preferred_Name" content="RNA Interference" datatype="rdf:PlainLiteral"></span><span id='am-124' property="rdfs:label" content="Novel mutation" datatype="rdf:PlainLiteral"></span><span id='am-125' property="Thesaurus:Preferred_Name" content="Induced mutation" datatype="rdf:PlainLiteral"></span><span id='am-126' property="Thesaurus:Preferred_Name" content="Deletion mutation" datatype="rdf:PlainLiteral"></span><span id='am-127' property="rdfs:label" content="lethal phenotype" datatype="rdf:PlainLiteral"></span><span id='am-128' property="Thesaurus:code" content="TEESS08" datatype="rdf:PlainLiteral"></span><span id='am-129' property="Thesaurus:Preferred_Name" content="Germline mutation" datatype="rdf:PlainLiteral"></span><span id='am-130' property="Thesaurus:code" content="TEESS13" datatype="rdf:PlainLiteral"></span><span id='am-131' property="rdfs:label" content="Missense mutation" datatype="rdf:PlainLiteral"></span><span id='am-132' property="rdfs:label" content="Frameshift mutation" datatype="rdf:PlainLiteral"></span><span id='am-133' property="Thesaurus:code" content="TEESS04" datatype="rdf:PlainLiteral"></span><span id='am-134' property="Thesaurus:code" content="TEESS07" datatype="rdf:PlainLiteral"></span><span id='am-135' property="Thesaurus:code" content="TEESS20" datatype="rdf:PlainLiteral"></span><span id='am-136' property="Thesaurus:code" content="TEESS21" datatype="rdf:PlainLiteral"></span><span id='am-137' property="rdfs:label" content="RNA interference pathway" datatype="rdf:PlainLiteral"></span><span id='am-138' property="Thesaurus:code" content="TEESS11" datatype="rdf:PlainLiteral"></span><span id='am-139' property="rdfs:label" content="Mutation" datatype="rdf:PlainLiteral"></span><span id='am-140' property="rdfs:label" content="phenotype" datatype="rdf:PlainLiteral"></span><span id='am-141' property="Thesaurus:Preferred_Name" content="Novel mutation" datatype="rdf:PlainLiteral"></span><span id='am-142' property="Thesaurus:Preferred_Name" content="Deleterious mutation" datatype="rdf:PlainLiteral"></span><span id='am-143' property="rdfs:label" content="Gene knockout" datatype="rdf:PlainLiteral"></span><span id='am-144' property="rdfs:label" content="null allele" datatype="rdf:PlainLiteral"></span><span id='am-145' property="Thesaurus:code" content="TEESS14" datatype="rdf:PlainLiteral"></span><span id='am-146' property="Thesaurus:code" content="TEESS06" datatype="rdf:PlainLiteral"></span><span id='am-147' property="Thesaurus:Preferred_Name" content="lethal phenotype" datatype="rdf:PlainLiteral"></span><span id='am-148' property="Thesaurus:code" content="TEESS15" datatype="rdf:PlainLiteral"></span><span id='am-149' property="Thesaurus:code" content="TEESS05" datatype="rdf:PlainLiteral"></span><span id='am-150' property="rdfs:label" content="knockout" datatype="rdf:PlainLiteral"></span><span id='am-151' property="Thesaurus:Preferred_Name" content="null allele" datatype="rdf:PlainLiteral"></span><span id='am-152' property="Thesaurus:Preferred_Name" content="Gene knockout" datatype="rdf:PlainLiteral"></span><span id='am-153' property="rdfs:label" content="RNA Interference" datatype="rdf:PlainLiteral"></span><span id='am-154' property="Thesaurus:Preferred_Name" content="survival" datatype="rdf:PlainLiteral"></span><span id='am-155' property="Thesaurus:code" content="TEESS09" datatype="rdf:PlainLiteral"></span><span id='am-156' property="Thesaurus:code" content="TEESS22" datatype="rdf:PlainLiteral"></span><span id='am-157' property="Thesaurus:code" content="TEESS25" datatype="rdf:PlainLiteral"></span><span id='am-158' property="Thesaurus:code" content="TEESS17" datatype="rdf:PlainLiteral"></span><span id='am-159' property="rdfs:label" content="Targeted mutation" datatype="rdf:PlainLiteral"></span><span id='am-160' property="rdfs:label" content="Induced mutation" datatype="rdf:PlainLiteral"></span>phenotype</span> mutant parasites, attempted establish stable clonal lines by <br /> limiting dilution. Unexpectedly, unable obtain viable clones did express either <br /> pfptpa pfpp2a genes. This confirmed fact cloned parasites expressed PfPTPA or <br /> PfPP2A detected RT-PCR (not shown). This suggests initial genomic integration was <br /> transitory and/or genes fact essential stage completion the <br /> intraerythrocytic cycle. The results related PfPP2A supported previous studies reporting that <br /> okadaic acid, inhibitor phosphatase activities, able drastically block blood parasite growth <br /> in vitro, suggesting essentiality phosphatases including PfPP2A [56]. Further studies still <br /> required examine essential functions precise timing proteins <br /> are critical parasite growth/development. This await development powerful and <br /> robust inducible expression Plasmodium falciparum proteins. A complementary approach <br /> to study function genes use inducible rodent Plasmodium or <br /> T. gondii. <br />  <br />       Figure 5. Genetic studies pfptpa pfpp2a. (a,b) Gene-targeting construct for <br />       gene disruption single homologous recombination using pCAM-BSD, the <br />       locus resulting integration <span id='am-317' about='Thesaurus:TESSE01' typeof='owl:Thing'><span id='am-318' property="rdfs:label" content="cell survival" datatype="rdf:PlainLiteral"></span><span id='am-319' property="Thesaurus:code" content="TEESS07" datatype="rdf:PlainLiteral"></span><span id='am-320' property="Thesaurus:code" content="TEESS03" datatype="rdf:PlainLiteral"></span><span id='am-321' property="Thesaurus:code" content="TEESS11" datatype="rdf:PlainLiteral"></span><span id='am-322' property="rdfs:label" content="knockout" datatype="rdf:PlainLiteral"></span><span id='am-323' property="rdfs:label" content="null allele" datatype="rdf:PlainLiteral"></span><span id='am-324' property="Thesaurus:Preferred_Name" content="Mutation" datatype="rdf:PlainLiteral"></span><span id='am-325' property="Thesaurus:code" content="TEESS20" datatype="rdf:PlainLiteral"></span><span id='am-326' property="Thesaurus:code" content="TEESS23" datatype="rdf:PlainLiteral"></span><span id='am-327' property="Thesaurus:code" content="TEESS15" datatype="rdf:PlainLiteral"></span><span id='am-328' property="Thesaurus:code" content="TEESS16" datatype="rdf:PlainLiteral"></span><span id='am-329' property="Thesaurus:code" content="TEESS10" datatype="rdf:PlainLiteral"></span><span id='am-330' property="Thesaurus:Preferred_Name" content="lethal phenotype" datatype="rdf:PlainLiteral"></span><span id='am-331' property="rdfs:label" content="Deleterious mutation" datatype="rdf:PlainLiteral"></span><span id='am-332' property="rdfs:label" content="Germline mutation" datatype="rdf:PlainLiteral"></span><span id='am-333' property="Thesaurus:Preferred_Name" content="RNA interference pathway" datatype="rdf:PlainLiteral"></span><span id='am-334' property="Thesaurus:code" content="TEESS21" datatype="rdf:PlainLiteral"></span><span id='am-335' property="Thesaurus:Preferred_Name" content="RNA Interference" datatype="rdf:PlainLiteral"></span><span id='am-336' property="rdfs:label" content="Nonsense mutation" datatype="rdf:PlainLiteral"></span><span id='am-337' property="rdfs:label" content="Targeted mutation" datatype="rdf:PlainLiteral"></span><span id='am-338' property="rdfs:label" content="RNA interference pathway" datatype="rdf:PlainLiteral"></span><span id='am-339' property="rdfs:label" content="Gene knockout" datatype="rdf:PlainLiteral"></span><span id='am-340' property="Thesaurus:Preferred_Name" content="Nonsense mutation" datatype="rdf:PlainLiteral"></span><span id='am-341' property="Thesaurus:code" content="TEESS14" datatype="rdf:PlainLiteral"></span><span id='am-342' property="Thesaurus:Preferred_Name" content="Targeted mutation" datatype="rdf:PlainLiteral"></span><span id='am-343' property="rdfs:label" content="Missense mutation" datatype="rdf:PlainLiteral"></span><span id='am-344' property="rdfs:label" content="Novel mutation" datatype="rdf:PlainLiteral"></span><span id='am-345' property="rdfs:label" content="Insertion mutation" datatype="rdf:PlainLiteral"></span><span id='am-346' property="Thesaurus:code" content="TEESS19" datatype="rdf:PlainLiteral"></span><span id='am-347' property="Thesaurus:Preferred_Name" content="Silent mutation" datatype="rdf:PlainLiteral"></span><span id='am-348' property="Thesaurus:code" content="TEESS13" datatype="rdf:PlainLiteral"></span><span id='am-349' property="Thesaurus:Preferred_Name" content="Point mutation" datatype="rdf:PlainLiteral"></span><span id='am-350' property="Thesaurus:Preferred_Name" content="Frameshift mutation" datatype="rdf:PlainLiteral"></span><span id='am-351' property="rdfs:label" content="Frameshift mutation" datatype="rdf:PlainLiteral"></span><span id='am-352' property="Thesaurus:Preferred_Name" content="Germline mutation" datatype="rdf:PlainLiteral"></span><span id='am-353' property="Thesaurus:Preferred_Name" content="phenotype" datatype="rdf:PlainLiteral"></span><span id='am-354' property="Thesaurus:Preferred_Name" content="null allele" datatype="rdf:PlainLiteral"></span><span id='am-355' property="Thesaurus:code" content="TEESS18" datatype="rdf:PlainLiteral"></span><span id='am-356' property="Thesaurus:Preferred_Name" content="Induced mutation" datatype="rdf:PlainLiteral"></span><span id='am-357' property="Thesaurus:code" content="TEESS12" datatype="rdf:PlainLiteral"></span><span id='am-358' property="Thesaurus:Preferred_Name" content="Deleterious mutation" datatype="rdf:PlainLiteral"></span><span id='am-359' property="Thesaurus:Preferred_Name" content="Novel mutation" datatype="rdf:PlainLiteral"></span><span id='am-360' property="rdfs:label" content="Mutation analysis" datatype="rdf:PlainLiteral"></span><span id='am-361' property="Thesaurus:code" content="TEESS01" datatype="rdf:PlainLiteral"></span><span id='am-362' property="Thesaurus:code" content="TEESS06" datatype="rdf:PlainLiteral"></span><span id='am-363' property="Thesaurus:Preferred_Name" content="cell survival" datatype="rdf:PlainLiteral"></span><span id='am-364' property="rdfs:label" content="Knock-out" datatype="rdf:PlainLiteral"></span><span id='am-365' property="Thesaurus:Preferred_Name" content="Missense mutation" datatype="rdf:PlainLiteral"></span><span id='am-366' property="Thesaurus:Preferred_Name" content="Gene mutation" datatype="rdf:PlainLiteral"></span><span id='am-367' property="rdfs:label" content="Deletion mutation" datatype="rdf:PlainLiteral"></span><span id='am-368' property="Thesaurus:Preferred_Name" content="Deletion mutation" datatype="rdf:PlainLiteral"></span><span id='am-369' property="rdfs:label" content="Induced mutation" datatype="rdf:PlainLiteral"></span><span id='am-370' property="Thesaurus:code" content="TEESS05" datatype="rdf:PlainLiteral"></span><span id='am-371' property="rdfs:label" content="survival" datatype="rdf:PlainLiteral"></span><span id='am-372' property="rdfs:label" content="null mutants" datatype="rdf:PlainLiteral"></span><span id='am-373' property="Thesaurus:code" content="TEESS22" datatype="rdf:PlainLiteral"></span><span id='am-374' property="Thesaurus:code" content="TEESS17" datatype="rdf:PlainLiteral"></span><span id='am-375' property="Thesaurus:Preferred_Name" content="survival" datatype="rdf:PlainLiteral"></span><span id='am-376' property="Thesaurus:Preferred_Name" content="Knock-out" datatype="rdf:PlainLiteral"></span><span id='am-377' property="Thesaurus:code" content="TEESS02" datatype="rdf:PlainLiteral"></span><span id='am-378' property="Thesaurus:Preferred_Name" content="Gene knockout" datatype="rdf:PlainLiteral"></span><span id='am-379' property="Thesaurus:Preferred_Name" content="knockout" datatype="rdf:PlainLiteral"></span><span id='am-380' property="Thesaurus:code" content="TEESS25" datatype="rdf:PlainLiteral"></span><span id='am-381' property="rdfs:label" content="lethal phenotype" datatype="rdf:PlainLiteral"></span><span id='am-382' property="rdfs:label" content="Mutation" datatype="rdf:PlainLiteral"></span><span id='am-383' property="Thesaurus:Preferred_Name" content="Mutation analysis" datatype="rdf:PlainLiteral"></span><span id='am-384' property="rdfs:label" content="Point mutation" datatype="rdf:PlainLiteral"></span><span id='am-385' property="rdfs:label" content="Silent mutation" datatype="rdf:PlainLiteral"></span><span id='am-386' property="Thesaurus:code" content="TEESS24" datatype="rdf:PlainLiteral"></span><span id='am-387' property="Thesaurus:Preferred_Name" content="null mutants" datatype="rdf:PlainLiteral"></span><span id='am-388' property="rdfs:label" content="RNA Interference" datatype="rdf:PlainLiteral"></span><span id='am-389' property="Thesaurus:code" content="TEESS08" datatype="rdf:PlainLiteral"></span><span id='am-390' property="Thesaurus:code" content="TEESS09" datatype="rdf:PlainLiteral"></span><span id='am-391' property="rdfs:label" content="Gene mutation" datatype="rdf:PlainLiteral"></span><span id='am-392' property="Thesaurus:code" content="TEESS04" datatype="rdf:PlainLiteral"></span><span id='am-393' property="rdfs:label" content="phenotype" datatype="rdf:PlainLiteral"></span><span id='am-394' property="Thesaurus:Preferred_Name" content="Insertion mutation" datatype="rdf:PlainLiteral"></span>knockout</span> pfptpa (a) pfpp2a (b) construct. <br />       (c,d) Analysis pCAM-BSD-pfptpa (c) pCAM-BSD-pfpp2a (d) transfected 3D7 <br />       culture PCR; lanes 1&#226;&#8364;&#8220;3 correspond DNA extracted transfected parasites; <br />       lanes 4&#226;&#8364;&#8220;6 correspond DNA extracted wild type parasites. Lanes 1 4 represent <br />       detection length wild type locus (PCR p9-p8 p31-p30 respectively); <br />       lanes 2 5 represent detection episomal DNA (PCR p10 p11); and <br />       lanes 3 6 represent detection integration insert (PCR p9-p11 and <br />       p31-p11 respectively). <br />  Int. J. Mol. Sci. 2014, 15                                                                       2442 <br />  <br />       Figure 6. Inhibition G2/M transition Xenopus oocytes PfPTPA. (a) Percentage of <br />       GVBD induced progesterone (PG), PfPTPA microinjection PfPTPA <br />       followed PG incubation; (b) Percentage GVBD induced PG incubation after <br />       microinjection different PfPTPA; (c) Binding PfPTPA XePP2A in <br />       Xenopus oocytes. Co-immunoprecipitation experiment PfPTPA-XePP2A complex <br />       anti-His antibodies (recognizing recombinant PfPTPA tagged 6-His) (lanes 2 <br />       3) microinjected Xenopus oocytes. The anti-mouse IgG antibody (lanes 1) was <br />       used control. Immunoprecipitates Xenopus oocytes microinjected water (&#226;&#710;&#8217;) <br />       PfPTPA (+) eluted, separated SDS-PAGE transferred nitrocellulose <br />       membrane. Immunoblot analysis performed anti-His antibodies (recognizing <br />       PfPTPA) (upper panel) anti-XePP2A antibodies (lower panel); (d) Effect PfPTPA on <br />       progesterone-dependent GVBD Xenopus oocytes. Percentage GVBD induced PG <br />       microinjection 10 ng PfPTPA WT mutated (n = 2). <br />  <br />  <br />  <br />  <br /> 2.6. Inhibition G2/M Transition Xenopus oocytes PfPTPA <br />  <br />    PP2A major Ser/Thr phosphatases dephosphorylate diverse proteins involved in <br /> the control eukaryotic cell cycle [57&#226;&#8364;&#8220;59]. In context Xenopus oocytes, inhibition PP2A <br /> promotes G2/M transition enabling activation M-Phase Promoting Factor, universal <br /> factor M-Phase entry. Thus, activity PP2A contributes block oocytes G2-like state <br /> while antagonizing MPF activation [60]. G2/M transition Xenopus oocytes triggered vitro <br /> by hormonal stimulation addition progesterone medium [61], provoking oocyte <br /> Germinal Vesicle Breakdown GVBD. If PfPTPA activates PP2A, preinjection oocytes will <br /> lead inhibition progesterone-induced maturation. With rationale mind, assessed the <br />  Int. J. Mol. Sci. 2014, 15                                                                       2443 <br />  <br /> impact PfPTPA G2/M transition induced progesterone. First, important emphasize <br /> that microinjection PfPTPA did produce GVBD (Figure 6a), however, expected <br /> the progesterone induced GVBD (Figure 6a). Results presented Figure 6a showed PfPTPA was <br /> able block GVBD induced progesterone. The threshold inhibition started be <br /> observed 10 ng/oocyte (Figure 6b). In parallel, important verify PfPTPA bind <br /> Xenopus PP2A (XePP2A). As shown Figure 6c, use specific PP2A antibodies immunoblot <br /> analysis eluates co-immunoprecipitated anti-His antibodies revealed presence of <br /> XePP2A complex early 15 mn post injection. This complex detectable 2 18 h <br /> post-injection, PfPTPA present oocyte extracts, suggesting early detection and <br /> rapid action PfPTPA. In model, propose PfPTPA activate PP2A consequently <br /> dephosphorylates key substrate required signal pathway activated progesterone. <br />    Next, used approach evaluate contribution activity amino acid residues <br /> involved PP2A binding. Results showed mutations V283A, G292A M296A completely <br /> abrogated function PfPTPA GVBD observed progesterone treatment <br /> (Figure 6d). It notable co-immunoprecipitation experiments showed mutated <br /> proteins exhibited strong decrease binding capacity XePP2A (Supplemental Figure S4). <br /> Concerning E272A K304A mutated proteins, loss function detectable. Altogether, these <br /> data confirmed role residue G292 showed residues V283 M296 participate also <br /> in function PfPTPA. However, residues E272 K304 did affect the <br /> binding function PfPTPA. <br />  <br /> 3. Experimental Section <br />  <br /> 3.1. Materials <br />  <br />     Plasmid pETDuet-1 purchased Novagen. Plasmids pCAM-BSD pCAM-BSD-HA <br /> were kind gift C. Doerig (Monash University, Melbourne, Australia) plasmid pARL kind <br /> gift C. Sanchez (Heidelberg, Germany). Protein phosphatase 2A C subunit (human recombinant) <br /> was purchased Cayman Chemical (Ann Arbor, MI 48108, USA). Monoclonal antibodies <br /> anti-PP2A alpha, anti-GFP, anti-penta His horseradish peroxidase-labeled anti-mouse IgG <br /> were purchased Abcam (Cambridge, UK), Roche (Basel, Switzerland), Qiagen (Venlo, <br /> The Netherlands) Santa Cruz Biotechnology (Santa Cruz, CA, USA) respectively. <br />  <br /> 3.2. Phylogenetic Analyses Secondary Structure Prediction <br />  <br />    Protein sequences (listed Supplemental Table S2) aligned using ClustalW algorithm <br /> implemented BioEdit v7.1 software (Ibis Biosciences, Carlsbad, CA, USA), manually <br /> corrected. Maximum likelihood trees built using MEGA5 [45] JTT + I + G model, with <br /> 100 bootstrap repetitions following species: Plasmodium falciparum, Plasmodium berghei, <br /> Plasmodium chabaudi, Plasmodium vivax, Plasmodium yoelii yoelii, Toxoplasma gondii, Arabidopsis <br /> thaliana, Homo sapiens, Mus musculus, Trypanosoma brucei, Tetrahymena thermophila, Xenopus <br /> laevis, Danio rerio, Saccharomyces cerevisiae, Theileria parva, Drosophila melanogaster, Leishmania <br /> major, Oryza sativa, Caenorhabditis elegans Schistosoma mansoni. <br />  Int. J. Mol. Sci. 2014, 15                                                                       2444 <br />  <br />    PfPTPA secondary prediction carried using ModWeb server [46]. <br />  <br /> 3.3. Preparation Parasites <br />  <br />    P. falciparum 3D7 clone grown according Trager et al. [62], RPMI-1640 medium <br /> supplemented 0.5% AlbuMAXTMII (Invitrogen, Paisley, Scotland, UK), 0.2 mM Hypoxanthin <br /> (CCPro, Oberdorla, Germany) 20 &#194;&#181;g/mL Gentamycin (Invitrogen), presence O+ <br /> erythrocytes. Cultures maintained 37 &#194;&#176;C humidified athmosphere (5% CO2). Parasites <br /> were synchronized double sorbitol treatment previously described [63]. To isolate total DNA or <br /> protein, parasitized erythrocytes lysed saponine [64] pelleted. Soluble protein extracts <br /> were prepared resuspending parasite pellet lysis buffer (20 mM Tris-HCl pH 7.4, 150 mM NaCl, <br /> 1% Triton X-100 EDTA-free protease inhibitor cocktail (Roche, Boulogne Billancourt, France) for <br /> one hour wheel 4 &#194;&#176;C followed sonication step. Total DNA extracted using KAPA <br /> Express Extract kit (KAPABioSystem, Montrouge, France) according manufacturer&#226;&#8364;&#8482;s protocol. <br /> Genomic DNA (gDNA) resuspended parasite pellet lysis buffer (50 mM Tris-HCl pH 7.5, <br /> 150 &#194;&#181;g/mL proteinase K 2% SDS) 2 h 55 &#194;&#176;C followed extraction steps with <br /> phenol-chloroform (addition 1 volume). gDNA precipitated 1/10th volume sodium <br /> acetate 2 volumes Ethanol 100%. gDNA washed twice resuspended H2O. <br />  <br /> 3.4. Localization PfPTPA PfPP2A <br />  <br />    All primers used study listed Supplemental Table S1. For episomal <br /> expression PfPTPA-GFP PfPP2A-GFP, full-length coding region pfptpa (Pf3D7_1430100) <br /> and pfpp2a (Pf3D7_0314400) amplified strand cDNA PCR using primers p3-p4 <br /> and p25-p26 respectively containing XhoI KpnI restriction sites. PCR fragments cloned into <br /> PCR2.1-TOPO vector (Invitrogen, San Diego, CA, USA) nucleotide sequences verified <br /> by sequencing (Eurofins, Ebersberg, Germany). PCR products subcloned frame GFP <br /> into pARL vector [51] digested XhoI KpnI. The plasmid carries human dhfr gene for <br /> selection WR99210 pfcrt promoter. Ring stages 3D7 parasites transfected with <br /> 100 &#194;&#181;g plasmid DNA electroporation, according Sidhu et al. [65]. The populations stably <br /> transfected parasites obtained weeks. Live parasites analyzed images were <br /> recorded fluorescence microscopy (LSM710, Zeiss, Marly le Roi, France). <br />  <br /> 3.5. Generation P. falciparum Transgenic Parasites <br />  <br />    The disruption pfptpa pfpp2a performed insertion PCR product <br /> corresponding 5&apos; portion PfPTPA (765 bp) PfPP2A (800 bp) sequences the <br /> pCAM-BSD vector contains cassette conferring resistance blasticidin. The insert obtained <br /> using 3D7 genomic DNA template oligonucleotides p5-p6 p27-p28 contain PstI <br /> and BamHI restriction sites respectively. <br />    P. falciparum parasites (ring stages) transfected described above. 48 h transfection, <br /> in order select transformed parasites, blasticidin (Invivogen, San Diego, CA, USA) added a <br />  Int. J. Mol. Sci. 2014, 15                                                                           2445 <br />  <br /> final concentration 2.5 &#194;&#181;g/mL. Resistant parasites appeared weeks were <br /> maintained drug selection. Populations stably transfected parasites obtained weeks. <br />  <br /> 3.6. Genotype Phenotype Analysis P. falciparum Transfectants <br />  <br />    Genotype pfptpa pfpp2a <span id='am-239' about='Thesaurus:TESSE01' typeof='owl:Thing'><span id='am-240' property="Thesaurus:Preferred_Name" content="null allele" datatype="rdf:PlainLiteral"></span><span id='am-241' property="Thesaurus:Preferred_Name" content="Induced mutation" datatype="rdf:PlainLiteral"></span><span id='am-242' property="Thesaurus:Preferred_Name" content="Targeted mutation" datatype="rdf:PlainLiteral"></span><span id='am-243' property="Thesaurus:Preferred_Name" content="Frameshift mutation" datatype="rdf:PlainLiteral"></span><span id='am-244' property="Thesaurus:code" content="TEESS05" datatype="rdf:PlainLiteral"></span><span id='am-245' property="Thesaurus:code" content="TEESS15" datatype="rdf:PlainLiteral"></span><span id='am-246' property="Thesaurus:Preferred_Name" content="Mutation analysis" datatype="rdf:PlainLiteral"></span><span id='am-247' property="Thesaurus:code" content="TEESS13" datatype="rdf:PlainLiteral"></span><span id='am-248' property="rdfs:label" content="RNA Interference" datatype="rdf:PlainLiteral"></span><span id='am-249' property="Thesaurus:code" content="TEESS24" datatype="rdf:PlainLiteral"></span><span id='am-250' property="Thesaurus:code" content="TEESS23" datatype="rdf:PlainLiteral"></span><span id='am-251' property="rdfs:label" content="Germline mutation" datatype="rdf:PlainLiteral"></span><span id='am-252' property="Thesaurus:Preferred_Name" content="Deleterious mutation" datatype="rdf:PlainLiteral"></span><span id='am-253' property="rdfs:label" content="null allele" datatype="rdf:PlainLiteral"></span><span id='am-254' property="rdfs:label" content="Missense mutation" datatype="rdf:PlainLiteral"></span><span id='am-255' property="Thesaurus:Preferred_Name" content="Knock-out" datatype="rdf:PlainLiteral"></span><span id='am-256' property="Thesaurus:code" content="TEESS14" datatype="rdf:PlainLiteral"></span><span id='am-257' property="rdfs:label" content="Nonsense mutation" datatype="rdf:PlainLiteral"></span><span id='am-258' property="Thesaurus:code" content="TEESS19" datatype="rdf:PlainLiteral"></span><span id='am-259' property="rdfs:label" content="Mutation" datatype="rdf:PlainLiteral"></span><span id='am-260' property="Thesaurus:Preferred_Name" content="Insertion mutation" datatype="rdf:PlainLiteral"></span><span id='am-261' property="rdfs:label" content="Silent mutation" datatype="rdf:PlainLiteral"></span><span id='am-262' property="Thesaurus:Preferred_Name" content="RNA Interference" datatype="rdf:PlainLiteral"></span><span id='am-263' property="rdfs:label" content="cell survival" datatype="rdf:PlainLiteral"></span><span id='am-264' property="rdfs:label" content="null mutants" datatype="rdf:PlainLiteral"></span><span id='am-265' property="Thesaurus:Preferred_Name" content="Gene knockout" datatype="rdf:PlainLiteral"></span><span id='am-266' property="rdfs:label" content="Gene knockout" datatype="rdf:PlainLiteral"></span><span id='am-267' property="Thesaurus:code" content="TEESS20" datatype="rdf:PlainLiteral"></span><span id='am-268' property="Thesaurus:code" content="TEESS07" datatype="rdf:PlainLiteral"></span><span id='am-269' property="Thesaurus:Preferred_Name" content="phenotype" datatype="rdf:PlainLiteral"></span><span id='am-270' property="rdfs:label" content="survival" datatype="rdf:PlainLiteral"></span><span id='am-271' property="rdfs:label" content="Point mutation" datatype="rdf:PlainLiteral"></span><span id='am-272' property="rdfs:label" content="phenotype" datatype="rdf:PlainLiteral"></span><span id='am-273' property="Thesaurus:code" content="TEESS16" datatype="rdf:PlainLiteral"></span><span id='am-274' property="rdfs:label" content="Deleterious mutation" datatype="rdf:PlainLiteral"></span><span id='am-275' property="Thesaurus:code" content="TEESS22" datatype="rdf:PlainLiteral"></span><span id='am-276' property="Thesaurus:code" content="TEESS01" datatype="rdf:PlainLiteral"></span><span id='am-277' property="Thesaurus:code" content="TEESS02" datatype="rdf:PlainLiteral"></span><span id='am-278' property="rdfs:label" content="Induced mutation" datatype="rdf:PlainLiteral"></span><span id='am-279' property="Thesaurus:Preferred_Name" content="Mutation" datatype="rdf:PlainLiteral"></span><span id='am-280' property="Thesaurus:code" content="TEESS25" datatype="rdf:PlainLiteral"></span><span id='am-281' property="Thesaurus:Preferred_Name" content="Nonsense mutation" datatype="rdf:PlainLiteral"></span><span id='am-282' property="Thesaurus:code" content="TEESS10" datatype="rdf:PlainLiteral"></span><span id='am-283' property="Thesaurus:Preferred_Name" content="survival" datatype="rdf:PlainLiteral"></span><span id='am-284' property="Thesaurus:Preferred_Name" content="Novel mutation" datatype="rdf:PlainLiteral"></span><span id='am-285' property="Thesaurus:Preferred_Name" content="Silent mutation" datatype="rdf:PlainLiteral"></span><span id='am-286' property="Thesaurus:code" content="TEESS21" datatype="rdf:PlainLiteral"></span><span id='am-287' property="rdfs:label" content="lethal phenotype" datatype="rdf:PlainLiteral"></span><span id='am-288' property="Thesaurus:Preferred_Name" content="null mutants" datatype="rdf:PlainLiteral"></span><span id='am-289' property="Thesaurus:code" content="TEESS06" datatype="rdf:PlainLiteral"></span><span id='am-290' property="rdfs:label" content="Mutation analysis" datatype="rdf:PlainLiteral"></span><span id='am-291' property="rdfs:label" content="Targeted mutation" datatype="rdf:PlainLiteral"></span><span id='am-292' property="Thesaurus:Preferred_Name" content="Germline mutation" datatype="rdf:PlainLiteral"></span><span id='am-293' property="rdfs:label" content="Knock-out" datatype="rdf:PlainLiteral"></span><span id='am-294' property="Thesaurus:code" content="TEESS11" datatype="rdf:PlainLiteral"></span><span id='am-295' property="Thesaurus:Preferred_Name" content="Point mutation" datatype="rdf:PlainLiteral"></span><span id='am-296' property="Thesaurus:code" content="TEESS09" datatype="rdf:PlainLiteral"></span><span id='am-297' property="rdfs:label" content="Frameshift mutation" datatype="rdf:PlainLiteral"></span><span id='am-298' property="Thesaurus:code" content="TEESS12" datatype="rdf:PlainLiteral"></span><span id='am-299' property="Thesaurus:Preferred_Name" content="Deletion mutation" datatype="rdf:PlainLiteral"></span><span id='am-300' property="Thesaurus:Preferred_Name" content="Gene mutation" datatype="rdf:PlainLiteral"></span><span id='am-301' property="rdfs:label" content="Novel mutation" datatype="rdf:PlainLiteral"></span><span id='am-302' property="Thesaurus:Preferred_Name" content="knockout" datatype="rdf:PlainLiteral"></span><span id='am-303' property="Thesaurus:code" content="TEESS17" datatype="rdf:PlainLiteral"></span><span id='am-304' property="rdfs:label" content="RNA interference pathway" datatype="rdf:PlainLiteral"></span><span id='am-305' property="Thesaurus:code" content="TEESS03" datatype="rdf:PlainLiteral"></span><span id='am-306' property="rdfs:label" content="knockout" datatype="rdf:PlainLiteral"></span><span id='am-307' property="Thesaurus:Preferred_Name" content="Missense mutation" datatype="rdf:PlainLiteral"></span><span id='am-308' property="Thesaurus:code" content="TEESS04" datatype="rdf:PlainLiteral"></span><span id='am-309' property="rdfs:label" content="Deletion mutation" datatype="rdf:PlainLiteral"></span><span id='am-310' property="rdfs:label" content="Insertion mutation" datatype="rdf:PlainLiteral"></span><span id='am-311' property="Thesaurus:Preferred_Name" content="lethal phenotype" datatype="rdf:PlainLiteral"></span><span id='am-312' property="Thesaurus:code" content="TEESS08" datatype="rdf:PlainLiteral"></span><span id='am-313' property="Thesaurus:Preferred_Name" content="cell survival" datatype="rdf:PlainLiteral"></span><span id='am-314' property="Thesaurus:Preferred_Name" content="RNA interference pathway" datatype="rdf:PlainLiteral"></span><span id='am-315' property="rdfs:label" content="Gene mutation" datatype="rdf:PlainLiteral"></span><span id='am-316' property="Thesaurus:code" content="TEESS18" datatype="rdf:PlainLiteral"></span>knock-out</span> parasites analyzed PCR genomic DNA using <br /> the primers p9 p31 respectively (derived 5&apos; non-translated region absent the <br /> construct) p11 specific pCAM-BSD vector. <br />    In order study phenotype knock-out parasites, cloning limiting dilution performed. <br /> Limiting dilutions set 96-well plates 3% hematocrit RPMI-1640 medium <br /> supplemented 0.5% AlbuMAXTMII, 0.2 mM Hypoxanthin, 20 &#194;&#181;g/mL Gentamycin and <br /> 2.5 &#194;&#181;g/mL blasticidin. Each contained 200 &#194;&#181;L medium average 0.1&#226;&#8364;&#8220;0.5 parasite. <br /> Medium changed day intervals beginning day seven. At day 21, smears were <br /> performed select positive wells. Six positive wells selected amplified. Cloning was <br /> verified PCR genomic extracted DNA primers p9-p8 pfptpa p31-p30 pfpp2a. <br />  <br /> 3.7. Recombinant Proteins Expression Purification <br />  <br />    In order obtain coding region PfPTPA, primers p1 p2 (Supplemental Table S1) were <br /> designed according sequence putative PfPTPA (Pf3D7_1430100) available Plasmodium <br /> Data <span id='am-473' about='xsp:base' typeof='owl:Thing'>Base</span> (PlasmoDB) (http://plasmodb.org/plasmo/). PCR performed strand cDNA from <br /> unsynchronized blood cultures P. falciparum 3D7 p1 p2 primers using Advantage 2 <br /> PCR kit (Clontech, St. Germain-en-Layes, France). PCR products cloned PCR 2.1-TOPO <br /> vector (Invitrogen) sequenced. Comparative analyses performed BIOEDIT software and <br /> ClustalW algorithm. After sequence analysis, coding region PfPTPA subcloned in <br /> pETDuet-1 allows expression protein fused histidines tag. <br />    With purpose produce recombinant PfPP2A protein, PCR performed strand <br /> cDNA unsynchronized blood cultures P. falciparum 3D7 p23 p24 primers. PCR <br /> products sequenced subcloned pETDuet-1 above. <br />    To obtain PfPTPA mutant constructs, carried PCR-based site-directed mutagenesis <br /> strategy using ISIS Proofreading DNA Polymerase. pETDuet-PfPTPA used template with <br /> primers p13-p14 (PfPTPA E272A), p15-p16 (PfPTPA V283A), p17-p18 (PfPTPA G292A), p19-p20 <br /> (PfPTPA M296A) p21-p22 (PfPTPA K304A). The PCR conditions consisted 1 min 95 &#194;&#176;C <br /> followed 16 cycles 95 &#194;&#176;C (30 s), 50 &#194;&#176;C (1 min) 72 &#194;&#176;C (9 min). The parental DNA plasmid <br /> was digested DpnI aliquot used transform XL10-Gold Ultracompetent cells <br /> (Stratagene, Amsterdam Zuidoost, The Netherlands). Mutated plasmids checked sequencing <br /> and used expression mutated PfPTPA recombinant proteins. A pfptpa-5mut gene <br /> containing mutations optimized codons synthetized (Genscript, Piscataway, NJ, <br /> USA) (Sequence presented Supplemental Figure S3). In order express PfPTPA-5mut recombinant <br /> protein, synthetic gene subcloned pETDuet vector. <br />    Expression PfPTPA-6His mutated PfPTPA-6His carried E. coli BL21 strain in <br /> the presence 0.5 mM IPTG 16 &#194;&#176;C overnight. Proteins extracted lysis buffer (20 mM <br /> Tris-HCl pH 7.4, 150 mM NaCl, 1% Triton X-100, lysozyme 1 mg/mL Protease inhibitor Cocktail <br />  Int. J. Mol. Sci. 2014, 15                                                                      2446 <br />  <br /> (Roche)) 1 h 4 &#194;&#176;C wheel followed sonication step. The extract loaded 1 mL <br /> nickel Ni-NTA column (Protino NiNTA, Macherey Nagel, D&#195;&#188;ren, Germany). Washing steps were <br /> carried buffer containing 20 mM Tris-HCl pH 7.4, 150 mM NaCl 20 mM Imidazole. <br /> Proteins eluted Imidazole gradient dialyzed 20 mM Tris-HCl pH 7.4, 150 mM NaCl. <br /> Under conditions, purity checked SDS-PAGE followed SimplyBlue&#226;&#8222;&#162; safe staining <br /> (Invitrogen, San Diego, CA, USA) &gt;90%. <br />    Several attempts produce PfPP2A using pETDuet plasmid containing coding <br /> region PfPP2A. Unfortunately, produce concentrated, soluble active <br /> recombinant PfPP2A protein. Considering sequence homology PfPP2A mammalian <br /> PP2A, activity interaction tests performed using Xenopus (endogene) Human PP2A <br /> (Cayman, Tallinn, Estonia). <br />  <br /> 3.8. RNA Synthesis PfPP2A <br />  <br />    Capped mRNA (cRNA) synthetized using T7 mMessage mMachine kit (Ambion, Austin, <br /> TX, USA). cRNA transcribed 1 &#194;&#181;g PfPP2A-pGBKT7 linearized BamHI (Fermentas, <br /> St. Leon-Rot, Germany). cRNA precipitated 2.5 M LiCl, washed 70% ethanol resuspended <br /> in 20 &#194;&#181;L diethyl pyrocarbonate-treated water quantified spectrophotometry. Finally 1 &#194;&#181;g of <br /> cRNA analyzed denaturing agarose gel. Gel staining 10 &#194;&#181;g/mL ethidium bromide <br /> allowed confirmation size PfPP2A cRNA absence abortive transcript. <br />  <br /> 3.9. Induction Xenopus Oocytes Germinal Vesicle Breakdown Co-Immunoprecipitation <br />  <br />    Preparation Xenopus laevis oocytes microinjection experiments performed as <br /> previously described [66]. Two approaches used. <br />    Briefly, assay, 20 oocytes removed animals pre-injected <br /> with His6-PfPTPA (wild type mutated) recombinant proteins 1 h incubation 10 &#194;&#181;M of <br /> human progesterone (Sigma, St. Louis, MO, USA). Progesterone used positive control of <br /> oocyte maturation. Preliminary experiments using different concentrations ranging 2 40 ng per <br /> injection showed 10 ng PfPTPA sufficient inhibit dramatically progesterone induced <br /> GVBD. GVBD detected appearance white spot apex animal pole 15 h. <br />    In order carry immunoprecipitation, oocyte extracts 20 oocytes removed least <br /> two animals prepared 15 min microinjection PfPTPA (WT mutated) as <br /> follows: oocytes lysed buffer (50 mM HEPES pH 7.4, 500 mM NaCl, 0.05% SDS, 0.5% <br /> Triton X100, 5 mM MgCl2, 1 mg/mL bovine serum albumin, 10 &#194;&#181;g/mL leupeptin, 10 &#194;&#181;g/mL aprotinin, <br /> 10 &#194;&#181;g/mL soybean trypsin inhibitor, 10 &#194;&#181;g/mL benzamidine, 1 mM PMSF, 1 mM sodium vanadate) <br /> and centrifuged 4 &#194;&#176;C 15 min 10,000g. To detect His6-PfPTPA proteins, electrophoresis <br /> followed western-blot analysis performed oocyte extracts. The membranes developed <br /> with anti-penta His antibodies (Qiagen, Courtaboeuf, France). <br />    A second approach used order test PfPTPA interaction PfPP2A. In assay, <br /> 20 oocytes removed different animals pre-injected PfPP2A cRNA <br /> 18 h microinjection wild-type mutated PfPTPA proteins. As control, PfPTPA <br /> recombinant protein injected alone. Oocyte extracts prepared 15 min microinjection to <br />  Int. J. Mol. Sci. 2014, 15                                                                        2447 <br />  <br /> detect interaction PfPP2A PfPTPA proteins. 180 &#194;&#181;L oocyte lysate PY buffer [67] were <br /> incubated 2 &#194;&#181;L antibodies 3 h 4 &#194;&#176;C rotation. Then, 50 &#194;&#181;L 50% solution <br /> protein A sepharose (Sigma, St. Louis, MO, USA) added 1 h. After washes of <br /> 15 min, beads resuspended 6 &#194;&#181;L buffer electrophoresis followed western-blot <br /> analysis performed. Co-immunoprecipitations using anti-His antibodies (Qiagen, <br /> Courtaboeuf, France), anti-Myc (Santa-Cruz Biotechnology, Heidelberg, Germany) anti-mouse <br /> antibodies control. The membranes revealed anti-Myc antibodies (Santa-Cruz <br /> Biotechnology) anti-His antibodies (Qiagen) (dilution 1/1000). Antibodies complexes were <br /> detected using Western blotting Luminol Reagent (sc-2048, Santa-Cruz Biotechnology). <br />  <br /> 3.10. Assays PP2A Effect PfPTPA <br />  <br />    Phosphatase assays carried buffer containing 40 mM Tris-HCl pH 8.4, 34 mM MgCl2, <br /> 4 mM EDTA, 2 mM DTT, 0.05 mg/mL Bovine serum albumin (BSA) 1 mM ATP 37 &#194;&#176;C during <br /> 30 min 20 mM para-NitroPhenyl Phosphate substrat (pNPP). Initial experiments performed <br /> to determine optimal conditions human PP2A activity. The reaction started adding <br /> 20 mM pNPP final volume 200 &#194;&#181;L. After incubation period 30 min 37 &#194;&#176;C, liberated <br /> para-Nitrophenol quantified measurement absorbance 405 nm. To investigate role of <br /> PfPTPA PP2A, 0.04 &#194;&#181;g human PP2A preincubated different quantities ranging from <br /> 0 0.4 &#194;&#181;g recombinant WT mutated PfPTPA 30 min 37 &#194;&#176;C testing PP2A <br /> phosphatase activity. <br />  <br /> 3.11. Measurement Binding PfPTPA PP2A <br />  <br />    Binding PfPTPA human PP2A assessed ELISA-based assay. Plates were <br /> coated 1 &#194;&#181;g/mL human PP2A BSA PBS overnight 4 &#194;&#176;C. Following washings with <br /> PBS-Tween 20 0.1%, plates blocked PBS-gelatin 1% 1 h room temperature. Coated <br /> plates incubated different concentrations PfPTPA (WT mutated), previously <br /> labeled biotin-N-hydroxysuccinimide according manufacturer&#226;&#8364;&#8482;s instructions (Calbiochem, <br /> Nottingham, UK). Incubation biotinylated-PfPTPA different proteins performed in <br /> PBS-Tween 20 0.1% 37 &#194;&#176;C 2 h. Following washes (as described above), binding was <br /> detected using streptavidin-horseradish peroxidase. After incubation time 20 min five <br /> washes, tetramethylbenzidine (TMB) (Uptima, Montlu&#195;&#167;on, France) added, reaction was <br /> stopped using 2N HCl. The optical density measured ELISA plate reader 450 nm. <br />  <br /> 4. Conclusions <br />  <br />     In work, report characterization PfPTPA, homolog human <br /> Phosphotyrosyl Phosphatase Activator, regulator PP2A. We showed direct interaction of <br /> PfPTPA PfPP2A assessed importance V283, G292 M296 residues this <br /> interaction absence interacting site. As expected, PfPTPA activates PP2A vitro a <br /> critical contribution G292 residue activity. Using Xenopus oocyte model, observed <br /> that microinjection PfPTPA blocked G2/M transition. PfPTPA essential the <br />  Int. J. Mol. Sci. 2014, 15                                                                        2448 <br />  <br /> completion intraerythrocytic lifecycle parasite. However, order elucidate exact <br /> role PTPA parasite cell cycle, assays conditional KO Plasmodium berghei under <br /> investigation. The confirmation essential role PTPA, suggest consideration this <br /> protein new lead drug design. <br />  <br /> Acknowledgments <br />  <br />    We thank Sophia Lafitte Caroline De Witte technical assistance Mathieu Vanderstraete <br /> for advice phylogenetic analysis. We thank Alain Martoriati helpful discussions. <br /> This work supported Inserm, CNRS University Lille Nord France. <br />  <br /> Conflicts Interest <br />  <br />      The authors declare conflict interest. <br />  <br /> References <br />  <br /> 1.  Manning, G.; Whyte, D.B.; Martinez, R.; Hunter, T.; Sudarsanam, S. The protein kinase <br />     complement human genome. Science 2002, 298, 1912&#226;&#8364;&#8220;1934. <br /> 2. Sacco, F.; Perfetto, L.; Castagnoli, L.; Cesareni, G. The human phosphatase interactome: An <br />     intricate family portrait. FEBS Lett. 2012, 586, 2732&#226;&#8364;&#8220;2739. <br /> 3. Bollen, M.; Peti, W.; Ragusa, M.J.; Beullens, M. The extended PP1 toolkit: Designed create <br />     specificity. Trends Biochem. Sci. 2010, 35, 450&#226;&#8364;&#8220;458. <br /> 4. Fardilha, M.; Esteves, S.L.; Korrodi-Gregorio, L.; da Cruz e Silva, O.A.; da Cruz e Silva, F.F. The <br />     physiological relevance protein phosphatase 1 interacting proteins health disease. <br />     Curr. Med. Chem. 2010, 17, 3996&#226;&#8364;&#8220;4017. <br /> 5. Hendrickx, A.; Beullens, M.; Ceulemans, H.; Den Abt, T.; van Eynde, A.; Nicolaescu, E.; <br />     Lesage, B.; Bollen, M. Docking motif-guided mapping interactome protein phosphatase-1. <br />     Chem. Biol. 2009, 16, 365&#226;&#8364;&#8220;371. <br /> 6. Cayla, X.; Goris, J.; Hermann, J.; Hendrix, P.; Ozon, R.; Merlevede, W. Isolation and <br />     characterization tyrosyl phosphatase activator rabbit skeletal muscle Xenopus laevis <br />     oocytes. Biochemistry 1990, 29, 658&#226;&#8364;&#8220;667. <br /> 7. Junttila, M.R.; Puustinen, P.; Niemela, M.; Ahola, R.; Arnold, H.; Bottzauw, T.; Ala-aho, R.; <br />     Nielsen, C.; Ivaska, J.; Taya, Y.; et al. CIP2A inhibits PP2A human malignancies. Cell 2007, <br />     130, 51&#226;&#8364;&#8220;62. <br /> 8. Kong, M.; Ditsworth, D.; Lindsten, T.; Thompson, C.B. Alpha4 essential regulator PP2A <br />     phosphatase activity. Mol. Cell 2009, 36, 51&#226;&#8364;&#8220;60. <br /> 9. Li, M.; Guo, H.; Damuni, Z. Purification characterization potent heat-stable protein <br />     inhibitors protein phosphatase 2A bovine kidney. Biochemistry 1995, 34, 1988&#226;&#8364;&#8220;1996. <br /> 10. Mochida, S.; Maslen, S.L.; Skehel, M.; Hunt, T. Greatwall phosphorylates inhibitor protein <br />     phosphatase 2A essential mitosis. Science 2010, 330, 1670&#226;&#8364;&#8220;1673. <br />  Int. J. Mol. Sci. 2014, 15                                                                           2449 <br />  <br /> 11. Smetana, J.H.; Zanchin, N.I. Interaction analysis heterotrimer formed phosphatase <br />     2A catalytic subunit, alpha 4 mammalian ortholog yeast Tip41 (TIPRL). FEBS J. 2007, <br />     274, 5891&#226;&#8364;&#8220;5904. <br /> 12. Bernal, M.; Sanchez-Romero, M.A.; Salas-Pino, S.; Daga, R.R. Regulation fission yeast <br />     morphogenesis PP2A activator pta2. PLoS One 2012, 7, e32823. <br /> 13. Mitchell, D.A.; Sprague, G.F., Jr. The PhosphoTyrosyl Phosphatase Activator, Ncs1p (Rrd1p), <br />     functions Cla4p regulate G(2)/M transition Saccharomyces cerevisiae. Mol. Cell. Biol. <br />     2001, 21, 488&#226;&#8364;&#8220;500. <br /> 14. Rempola, B.; Kaniak, A.; Migdalski, A.; Rytka, J.; Slonimski, P.P.; di Rago, J.P. Functional <br />     analysis RRD1 (YIL153w) RRD2 (YPL152w), encode putative activators the <br />     PhosphoTyrosyl Phosphatase Activity PP2A Saccharomyces cerevisiae. Mol. Gen. Genet.: <br />     MGG 2000, 262, 1081&#226;&#8364;&#8220;1092. <br /> 15. Van Hoof, C.; Janssens, V.; Baere, I.; Winde, J.H.; Winderickx, J.; Dumortier, F.; <br />     Thevelein, J.M.; Merlevede, W.; Goris, J. The Saccharomyces cerevisiae homologue YPA1 the <br />     mammalian PhosphoTyrosyl Phosphatase Activator protein phosphatase 2A controls <br />     progression G1 phase yeast cell cycle. J. Mol. Biol. 2000, 302, 103&#226;&#8364;&#8220;120. <br /> 16. Van Hoof, C.; Janssens, V.; Baere, I.; Stark, M.J.; Winde, J.H.; Winderickx, J.; Thevelein, J.M.; <br />     Merlevede, W.; Goris, J. The Saccharomyces cerevisiae PhosphoTyrosyl Phosphatase Activator <br />     proteins required subset functions disrupted protein phosphatase 2A mutations. <br />     Exp. Cell Res. 2001, 264, 372&#226;&#8364;&#8220;387. <br /> 17. Cayla, X.; van Hoof, C.; Bosch, M.; Waelkens, E.; Vandekerckhove, J.; Peeters, B.; Merlevede, W.; <br />     Goris, J. Molecular cloning, expression, characterization PTPA, protein activates the <br />     tyrosyl phosphatase activity protein phosphatase 2A. J. Biol. Chem. 1994, 269, 15668&#226;&#8364;&#8220;15675. <br /> 18. Van Hoof, C.; Janssens, V.; Dinishiotu, A.; Merlevede, W.; Goris, J. Functional analysis of <br />     conserved domains PhosphoTyrosyl Phosphatase Activator. Molecular cloning the <br />     homologues Drosophila melanogaster Saccharomyces cerevisiae. Biochemistry 1998, <br />     37, 12899&#226;&#8364;&#8220;12908. <br /> 19. Jordens, J.; Janssens, V.; Longin, S.; Stevens, I.; Martens, E.; Bultynck, G.; Engelborghs, Y.; <br />     Lescrinier, E.; Waelkens, E.; Goris, J.; et al. The protein phosphatase 2A phosphatase activator is <br />     novel peptidyl-prolyl cis/trans-isomerase. J. Biol. Chem. 2006, 281, 6349&#226;&#8364;&#8220;6357. <br /> 20. Chao, Y.; Xing, Y.; Chen, Y.; Xu, Y.; Lin, Z.; Li, Z.; Jeffrey, P.D.; Stock, J.B.; Shi, Y. Structure <br />     mechanism PhosphoTyrosyl Phosphatase Activator. Mol. Cell 2006, 23, 535&#226;&#8364;&#8220;546. <br /> 21. Leulliot, N.; Vicentini, G.; Jordens, J.; Quevillon-Cheruel, S.; Schiltz, M.; Barford, D.; <br />     van Tilbeurgh, H.; Goris, J. Crystal structure PP2A phosphatase activator: Implications for <br />     PP2A-specific PPIase activity. Mol. Cell 2006, 23, 413&#226;&#8364;&#8220;424. <br /> 22. Magnusdottir, A.; Stenmark, P.; Flodin, S.; Nyman, T.; Hammarstrom, M.; Ehn, M.; Bakali, H.M.; <br />     Berglund, H.; Nordlund, P. The crystal structure human PP2A phosphatase activator reveals a <br />     novel fold highly conserved cleft implicated protein-protein interactions. J. Biol. Chem. <br />     2006, 281, 22434&#226;&#8364;&#8220;22438. <br /> 23. Bhattacharyya, M.K.; Hong, Z.; Kongkasuriyachai, D.; Kumar, N. Plasmodium falciparum <br />     protein phosphatase type 1 functionally complements glc7 mutant Saccharomyces cerevisiae. <br />     Int. J. Parasitol. 2002, 32, 739&#226;&#8364;&#8220;747. <br />  Int. J. Mol. Sci. 2014, 15                                                                         2450 <br />  <br /> 24. Blisnick, T.; Vincensini, L.; Fall, G.; Braun-Breton, C. Protein phosphatase 1, a <br />     Plasmodium falciparum essential enzyme, exported host cell implicated release <br />     infectious merozoites. Cell. Microbiol. 2006, 8, 591&#226;&#8364;&#8220;601. <br /> 25. Dobson, S.; Kar, B.; Kumar, R.; Adams, B.; Barik, S. A novel tetratricopeptide repeat (TPR) <br />     containing PP5 serine/threonine protein phosphatase malaria parasite, Plasmodium falciparum. <br />     BMC Microbiol. 2001, 1, 31. <br /> 26. Dobson, S.; May, T.; Berriman, M.; del Vecchio, C.; Fairlamb, A.H.; Chakrabarti, D.; Barik, S. <br />     Characterization protein Ser/Thr phosphatases malaria parasite, Plasmodium falciparum: <br />     Inhibition parasitic calcineurin cyclophilin-cyclosporin complex. Mol. Biochem. Parasitol. <br />     1999, 99, 167&#226;&#8364;&#8220;181. <br /> 27. Fernandez-Pol, S.; Slouka, Z.; Bhattacharjee, S.; Fedotova, Y.; Freed, S.; An, X.; Holder, A.A.; <br />     Campanella, E.; Low, P.S.; Mohandas, N.; et al. A bacterial phosphatase-like enzyme the <br />     malaria parasite Plasmodium falciparum possesses tyrosine phosphatase activity implicated <br />     regulation band 3 dynamics parasite invasion. Eukaryot. Cell 2013, 12, 1179&#226;&#8364;&#8220;1191. <br /> 28. Guttery, D.S.; Poulin, B.; Ferguson, D.J.; Szoor, B.; Wickstead, B.; Carroll, P.L.; Ramakrishnan, C.; <br />     Brady, D.; Patzewitz, E.M.; Straschil, U.; et al. A unique protein phosphatase kelch-like <br />     domains (PPKL) Plasmodium modulates ookinete differentiation, motility invasion. <br />     PLoS Pathog. 2012, 8, e1002948. <br /> 29. Kumar, R.; Adams, B.; Oldenburg, A.; Musiyenko, A.; Barik, S. Characterisation expression <br />     PP1 serine/threonine protein phosphatase (PfPP1) malaria parasite, <br />     Plasmodium falciparum: Demonstration essential role using <span id='am-395' about='Thesaurus:TESSE01' typeof='owl:Thing'><span id='am-396' property="Thesaurus:Preferred_Name" content="Mutation analysis" datatype="rdf:PlainLiteral"></span><span id='am-397' property="Thesaurus:code" content="TEESS02" datatype="rdf:PlainLiteral"></span><span id='am-398' property="rdfs:label" content="Missense mutation" datatype="rdf:PlainLiteral"></span><span id='am-399' property="Thesaurus:code" content="TEESS15" datatype="rdf:PlainLiteral"></span><span id='am-400' property="rdfs:label" content="lethal phenotype" datatype="rdf:PlainLiteral"></span><span id='am-401' property="Thesaurus:Preferred_Name" content="Silent mutation" datatype="rdf:PlainLiteral"></span><span id='am-402' property="Thesaurus:Preferred_Name" content="RNA Interference" datatype="rdf:PlainLiteral"></span><span id='am-403' property="Thesaurus:Preferred_Name" content="knockout" datatype="rdf:PlainLiteral"></span><span id='am-404' property="Thesaurus:code" content="TEESS09" datatype="rdf:PlainLiteral"></span><span id='am-405' property="Thesaurus:Preferred_Name" content="null allele" datatype="rdf:PlainLiteral"></span><span id='am-406' property="rdfs:label" content="Insertion mutation" datatype="rdf:PlainLiteral"></span><span id='am-407' property="Thesaurus:code" content="TEESS21" datatype="rdf:PlainLiteral"></span><span id='am-408' property="rdfs:label" content="Mutation analysis" datatype="rdf:PlainLiteral"></span><span id='am-409' property="rdfs:label" content="Frameshift mutation" datatype="rdf:PlainLiteral"></span><span id='am-410' property="rdfs:label" content="Point mutation" datatype="rdf:PlainLiteral"></span><span id='am-411' property="rdfs:label" content="Knock-out" datatype="rdf:PlainLiteral"></span><span id='am-412' property="Thesaurus:code" content="TEESS08" datatype="rdf:PlainLiteral"></span><span id='am-413' property="Thesaurus:code" content="TEESS18" datatype="rdf:PlainLiteral"></span><span id='am-414' property="rdfs:label" content="cell survival" datatype="rdf:PlainLiteral"></span><span id='am-415' property="Thesaurus:code" content="TEESS23" datatype="rdf:PlainLiteral"></span><span id='am-416' property="Thesaurus:Preferred_Name" content="survival" datatype="rdf:PlainLiteral"></span><span id='am-417' property="Thesaurus:code" content="TEESS04" datatype="rdf:PlainLiteral"></span><span id='am-418' property="Thesaurus:Preferred_Name" content="Mutation" datatype="rdf:PlainLiteral"></span><span id='am-419' property="Thesaurus:code" content="TEESS19" datatype="rdf:PlainLiteral"></span><span id='am-420' property="Thesaurus:Preferred_Name" content="Nonsense mutation" datatype="rdf:PlainLiteral"></span><span id='am-421' property="Thesaurus:code" content="TEESS20" datatype="rdf:PlainLiteral"></span><span id='am-422' property="rdfs:label" content="RNA interference pathway" datatype="rdf:PlainLiteral"></span><span id='am-423' property="rdfs:label" content="Gene mutation" datatype="rdf:PlainLiteral"></span><span id='am-424' property="Thesaurus:code" content="TEESS11" datatype="rdf:PlainLiteral"></span><span id='am-425' property="Thesaurus:code" content="TEESS17" datatype="rdf:PlainLiteral"></span><span id='am-426' property="Thesaurus:Preferred_Name" content="Knock-out" datatype="rdf:PlainLiteral"></span><span id='am-427' property="Thesaurus:Preferred_Name" content="Frameshift mutation" datatype="rdf:PlainLiteral"></span><span id='am-428' property="rdfs:label" content="Deletion mutation" datatype="rdf:PlainLiteral"></span><span id='am-429' property="rdfs:label" content="Novel mutation" datatype="rdf:PlainLiteral"></span><span id='am-430' property="Thesaurus:code" content="TEESS07" datatype="rdf:PlainLiteral"></span><span id='am-431' property="Thesaurus:Preferred_Name" content="Targeted mutation" datatype="rdf:PlainLiteral"></span><span id='am-432' property="rdfs:label" content="Nonsense mutation" datatype="rdf:PlainLiteral"></span><span id='am-433' property="Thesaurus:code" content="TEESS14" datatype="rdf:PlainLiteral"></span><span id='am-434' property="Thesaurus:Preferred_Name" content="Germline mutation" datatype="rdf:PlainLiteral"></span><span id='am-435' property="Thesaurus:code" content="TEESS12" datatype="rdf:PlainLiteral"></span><span id='am-436' property="Thesaurus:code" content="TEESS22" datatype="rdf:PlainLiteral"></span><span id='am-437' property="Thesaurus:Preferred_Name" content="Novel mutation" datatype="rdf:PlainLiteral"></span><span id='am-438' property="Thesaurus:code" content="TEESS05" datatype="rdf:PlainLiteral"></span><span id='am-439' property="rdfs:label" content="Mutation" datatype="rdf:PlainLiteral"></span><span id='am-440' property="rdfs:label" content="RNA Interference" datatype="rdf:PlainLiteral"></span><span id='am-441' property="rdfs:label" content="Targeted mutation" datatype="rdf:PlainLiteral"></span><span id='am-442' property="Thesaurus:Preferred_Name" content="Missense mutation" datatype="rdf:PlainLiteral"></span><span id='am-443' property="Thesaurus:Preferred_Name" content="Deletion mutation" datatype="rdf:PlainLiteral"></span><span id='am-444' property="Thesaurus:Preferred_Name" content="Gene mutation" datatype="rdf:PlainLiteral"></span><span id='am-445' property="rdfs:label" content="null allele" datatype="rdf:PlainLiteral"></span><span id='am-446' property="rdfs:label" content="survival" datatype="rdf:PlainLiteral"></span><span id='am-447' property="Thesaurus:Preferred_Name" content="Deleterious mutation" datatype="rdf:PlainLiteral"></span><span id='am-448' property="Thesaurus:Preferred_Name" content="RNA interference pathway" datatype="rdf:PlainLiteral"></span><span id='am-449' property="Thesaurus:code" content="TEESS06" datatype="rdf:PlainLiteral"></span><span id='am-450' property="rdfs:label" content="Deleterious mutation" datatype="rdf:PlainLiteral"></span><span id='am-451' property="Thesaurus:code" content="TEESS24" datatype="rdf:PlainLiteral"></span><span id='am-452' property="Thesaurus:Preferred_Name" content="Gene knockout" datatype="rdf:PlainLiteral"></span><span id='am-453' property="rdfs:label" content="Gene knockout" datatype="rdf:PlainLiteral"></span><span id='am-454' property="rdfs:label" content="Induced mutation" datatype="rdf:PlainLiteral"></span><span id='am-455' property="Thesaurus:code" content="TEESS01" datatype="rdf:PlainLiteral"></span><span id='am-456' property="Thesaurus:code" content="TEESS25" datatype="rdf:PlainLiteral"></span><span id='am-457' property="Thesaurus:Preferred_Name" content="Insertion mutation" datatype="rdf:PlainLiteral"></span><span id='am-458' property="rdfs:label" content="Silent mutation" datatype="rdf:PlainLiteral"></span><span id='am-459' property="rdfs:label" content="knockout" datatype="rdf:PlainLiteral"></span><span id='am-460' property="Thesaurus:code" content="TEESS16" datatype="rdf:PlainLiteral"></span><span id='am-461' property="rdfs:label" content="Germline mutation" datatype="rdf:PlainLiteral"></span><span id='am-462' property="rdfs:label" content="null mutants" datatype="rdf:PlainLiteral"></span><span id='am-463' property="rdfs:label" content="phenotype" datatype="rdf:PlainLiteral"></span><span id='am-464' property="Thesaurus:code" content="TEESS03" datatype="rdf:PlainLiteral"></span><span id='am-465' property="Thesaurus:code" content="TEESS10" datatype="rdf:PlainLiteral"></span><span id='am-466' property="Thesaurus:Preferred_Name" content="Induced mutation" datatype="rdf:PlainLiteral"></span><span id='am-467' property="Thesaurus:Preferred_Name" content="phenotype" datatype="rdf:PlainLiteral"></span><span id='am-468' property="Thesaurus:Preferred_Name" content="null mutants" datatype="rdf:PlainLiteral"></span><span id='am-469' property="Thesaurus:Preferred_Name" content="cell survival" datatype="rdf:PlainLiteral"></span><span id='am-470' property="Thesaurus:Preferred_Name" content="lethal phenotype" datatype="rdf:PlainLiteral"></span><span id='am-471' property="Thesaurus:code" content="TEESS13" datatype="rdf:PlainLiteral"></span><span id='am-472' property="Thesaurus:Preferred_Name" content="Point mutation" datatype="rdf:PlainLiteral"></span>RNA interference</span>. Malar. J. <br />     2002, 1, 5. <br /> 30. Kumar, R.; Musiyenko, A.; Barik, S. Plasmodium falciparum calcineurin association with <br />     heat shock protein 90: Mechanisms antimalarial activity cyclosporin A synergism <br />     geldanamycin. Mol. Biochem. Parasitol. 2005, 141, 29&#226;&#8364;&#8220;37. <br /> 31. Kumar, R.; Musiyenko, A.; Oldenburg, A.; Adams, B.; Barik, S. Post-translational generation of <br />     constitutively active cores larger phosphatases malaria parasite, Plasmodium falciparum: <br />     Implications proteomics. BMC Mol. Biol. 2004, 5, 6. <br /> 32. Li, J.L.; Baker, D.A. Protein phosphatase beta, putative type-2A protein phosphatase the <br />     human malaria parasite Plasmodium falciparum. Eur. J. Biochem./FEBS 1997, 249, 98&#226;&#8364;&#8220;106. <br /> 33. Li, J.L.; Baker, D.A. A putative protein serine/threonine phosphatase Plasmodium falciparum <br />     contains large N-terminal extension unique inserts catalytic domain. <br />     Mol. Biochem. Parasitol. 1998, 95, 287&#226;&#8364;&#8220;295. <br /> 34. Lindenthal, C.; Klinkert, M.Q. Identification biochemical characterisation protein <br />     phosphatase 5 homologue Plasmodium falciparum. Mol. Biochem. Parasitol. 2002, 120, <br />     257&#226;&#8364;&#8220;268. <br /> 35. Mamoun, C.B.; Goldberg, D.E. Plasmodium protein phosphatase 2C dephosphorylates translation <br />     elongation factor 1beta inhibits PKC-mediated nucleotide exchange activity vitro. <br />     Mol. Microbiol. 2001, 39, 973&#226;&#8364;&#8220;981. <br /> 36. Mamoun, C.B.; Sullivan, D.J., Jr.; Banerjee, R.; Goldberg, D.E. Identification and <br />     characterization unusual double serine/threonine protein phosphatase 2C malaria <br />     parasite Plasmodium falciparum. J. Biol. Chem. 1998, 273, 11241&#226;&#8364;&#8220;11247. <br />  Int. J. Mol. Sci. 2014, 15                                                                           2451 <br />  <br /> 37. Patzewitz, E.M.; Guttery, D.S.; Poulin, B.; Ramakrishnan, C.; Ferguson, D.J.; Wall, R.J.; Brady, D.; <br />     Holder, A.A.; Szoor, B.; Tewari, R. An ancient protein phosphatase, SHLP1, critical microneme <br />     development Plasmodium ookinetes parasite transmission. Cell Rep. 2013, 3, 622&#226;&#8364;&#8220;629. <br /> 38. Philip, N.; Vaikkinen, H.J.; Tetley, L.; Waters, A.P. A unique Kelch domain phosphatase <br />     Plasmodium regulates ookinete morphology, motility invasion. PLoS One 2012, 7, <br />     e44617. <br /> 39. Singh, S.; More, K.R.; Chitnis, C.E. Role calcineurin actin dynamics regulated secretion <br />     microneme proteins Plasmodium falciparum merozoites erythrocyte invasion. <br />     Cell. Microbiol. 2013, doi:10.1111/cmi.12177. <br /> 40. Daher, W.; Browaeys, E.; Pierrot, C.; Jouin, H.; Dive, D.; Meurice, E.; Dissous, C.; Capron, M.; <br />     Tomavo, S.; Doerig, C.; et al. Regulation protein phosphatase type 1 cell cycle <br />     progression PfLRR1, novel leucine-rich repeat protein human malaria parasite <br />     Plasmodium falciparum. Mol. Microbiol. 2006, 60, 578&#226;&#8364;&#8220;590. <br /> 41. Freville, A.; Cailliau-Maggio, K.; Pierrot, C.; Tellier, G.; Kalamou, H.; Lafitte, S.; Martoriati, A.; <br />     Pierce, R.J.; Bodart, J.F.; Khalife, J. Plasmodium falciparum encodes conserved active <br />     inhibitor-2 Protein Phosphatase type 1: Perspectives novel anti-plasmodial therapy. <br />     BMC Biol. 2013, 11, 80. <br /> 42. Freville, A.; Landrieu, I.; Garcia-Gimeno, M.A.; Vicogne, J.; Montbarbon, M.; Bertin, B.; <br />     Verger, A.; Kalamou, H.; Sanz, P.; Werkmeister, E.; et al. Plasmodium falciparum inhibitor-3 <br />     homolog increases protein phosphatase type 1 activity essential parasitic survival. <br />     J. Biol. Chem. 2012, 287, 1306&#226;&#8364;&#8220;1321. <br /> 43. Dobson, S.; Kumar, R.; Bracchi-Ricard, V.; Freeman, S.; Al-Murrani, S.W.; Johnson, C.; <br />     Damuni, Z.; Chakrabarti, D.; Barik, S. Characterization unique aspartate-rich protein the <br />     SET/TAF-family human malaria parasite, Plasmodium falciparum, inhibits protein <br />     phosphatase 2A. Mol. Biochem. Parasitol. 2003, 126, 239&#226;&#8364;&#8220;250. <br /> 44. Aurrecoechea, C.; Brestelli, J.; Brunk, B.P.; Dommer, J.; Fischer, S.; Gajria, B.; Gao, X.; Gingle, A.; <br />     Grant, G.; Harb, O.S.; et al. PlasmoDB: A functional genomic database malaria parasites. <br />     Nucleic Acids Res. 2009, 37, D539&#226;&#8364;&#8220;D543. <br /> 45. Tamura, K.; Peterson, D.; Peterson, N.; Stecher, G.; Nei, M.; Kumar, S. MEGA5: Molecular <br />     evolutionary genetics analysis using maximum likelihood, evolutionary distance, maximum <br />     parsimony methods. Mol. Biol. Evol. 2011, 28, 2731&#226;&#8364;&#8220;2739. <br /> 46. Pieper, U.; Webb, B.M.; Barkan, D.T.; Schneidman-Duhovny, D.; Schlessinger, A.; Braberg, H.; <br />     Yang, Z.; Meng, E.C.; Pettersen, E.F.; Huang, C.C.; et al. ModBase, database annotated <br />     comparative protein structure models, associated resources. Nucleic Acids Res. 2011, 39, <br />     D465&#226;&#8364;&#8220;D474. <br /> 47. Bowyer, P.W.; Simon, G.M.; Cravatt, B.F.; Bogyo, M. Global profiling proteolysis during <br />     rupture Plasmodium falciparum host erythrocyte. Mol. Cell. Proteomics 2011, 10, <br />     doi:10.1074/mcp.M110.001636. <br /> 48. Lopez-Barragan, M.J.; Lemieux, J.; Quinones, M.; Williamson, K.C.; Molina-Cruz, A.; Cui, K.; <br />     Barillas-Mury, C.; Zhao, K.; Su, X.Z. Directional gene expression antisense transcripts in <br />     sexual asexual stages Plasmodium falciparum. BMC Genomics 2011, 12, 587. <br />  Int. J. Mol. Sci. 2014, 15                                                                           2452 <br />  <br /> 49. Treeck, M.; Sanders, J.L.; Elias, J.E.; Boothroyd, J.C. The phosphoproteomes of <br />     Plasmodium falciparum Toxoplasma gondii reveal unusual adaptations the <br />     parasites&#226;&#8364;&#8482; boundaries. Cell Host Microbe 2011, 10, 410&#226;&#8364;&#8220;419. <br /> 50. Longin, S.; Jordens, J.; Martens, E.; Stevens, I.; Janssens, V.; Rondelez, E.; Baere, I.; Derua, R.; <br />     Waelkens, E.; Goris, J.; et al. An inactive protein phosphatase 2A population associated with <br />     methylesterase re-activated PhosphoTyrosyl Phosphatase Activator. Biochem. J. <br />     2004, 380, 111&#226;&#8364;&#8220;119. <br /> 51. Kuhn, Y.; Sanchez, C.P.; Ayoub, D.; Saridaki, T.; van Dorsselaer, A.; Lanzer, M. Trafficking of <br />     phosphoprotein PfCRT digestive vacuolar membrane Plasmodium falciparum. <br />     Traffic 2010, 11, 236&#226;&#8364;&#8220;249. <br /> 52. Lee, T.Y.; Lai, T.Y.; Lin, S.C.; Wu, C.W.; Ni, I.F.; Yang, Y.S.; Hung, L.Y.; Law, B.K.; <br />     Chiang, C.W. The B56gamma3 regulatory subunit protein phosphatase 2A (PP2A) regulates S <br />     phase-specific nuclear accumulation PP2A G1 S transition. J. Biol. Chem. 2010, 285, <br />     21567&#226;&#8364;&#8220;21580. <br /> 53. Van Hoof, C.; Martens, E.; Longin, S.; Jordens, J.; Stevens, I.; Janssens, V.; Goris, J. Specific <br />     interactions PP2A PP2A-like phosphatases yeast PTPA homologues, Ypa1 and <br />     Ypa2. Biochem. J. 2005, 386, 93&#226;&#8364;&#8220;102. <br /> 54. Kinoshita, N.; Ohkura, H.; Yanagida, M. Distinct, essential roles type 1 2A protein <br />     phosphatases control fission yeast cell division cycle. Cell 1990, 63, 405&#226;&#8364;&#8220;415. <br /> 55. Gotz, J.; Probst, A.; Ehler, E.; Hemmings, B.; Kues, W. Delayed embryonic lethality mice <br />     lacking protein phosphatase 2A catalytic subunit Calpha. Proc. Natl. Acad. Sci. USA 1998, 95, <br />     12370&#226;&#8364;&#8220;12375. <br /> 56. Yokoyama, D.; Saito-Ito, A.; Asao, N.; Tanabe, K.; Yamamoto, M.; Matsumura, T. Modulation of <br />     growth Plasmodium falciparum vitro protein serine/threonine phosphatase inhibitors. <br />     Biochem. Biophys. Res. Commun. 1998, 247, 18&#226;&#8364;&#8220;23. <br /> 57. Jeong, A.L.; Yang, Y. PP2A function mitotic kinases substrates cell cycle. <br />     BMB Rep. 2013, 46, 289&#226;&#8364;&#8220;294. <br /> 58. Jiang, Y. Regulation cell cycle protein phosphatase 2A Saccharomyces cerevisiae. <br />     Microbiol. Mol. Biol. Rev. 2006, 70, 440&#226;&#8364;&#8220;449. <br /> 59. Krasinska, L.; Domingo-Sananes, M.R.; Kapuy, O.; Parisis, N.; Harker, B.; Moorhead, G.; <br />     Rossignol, M.; Novak, B.; Fisher, D. Protein phosphatase 2A controls order dynamics of <br />     cell-cycle transitions. Mol. Cell 2011, 44, 437&#226;&#8364;&#8220;450. <br /> 60. Lorca, T.; Bernis, C.; Vigneron, S.; Burgess, A.; Brioudes, E.; Labbe, J.C.; Castro, A. Constant <br />     regulation MPF amplification loop Greatwall-PP2A pathway required for <br />     metaphase II arrest correct entry embryonic cell cycle. J. Cell Sci. 2010, 123, <br />     2281&#226;&#8364;&#8220;2291. <br /> 61. Ferrell, J.E., Jr. Xenopus oocyte maturation: New lessons good egg. BioEssays 1999, 21, <br />     833&#226;&#8364;&#8220;842. <br /> 62. Trager, W.; Jensen, J.B. Human malaria parasites continuous culture. Science 1976, 193, 673&#226;&#8364;&#8220;675 <br /> </body></html>